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Abstract 
 
The use of plants and their health benefits have been recognized over the years.   Its 
use and consumption of herbal dietary supplements has increased in the last years in United 
States and Europe. Internet is one of the most required options to buy dietary supplements 
(DS). Several studies suggest that information on most sites is incomplete, poorly 
referenced, and may contain illegal claims. Thus, a conscious and informed decision is 
essential for consumers. Camellia sinensis, also known as green tea, is one of the most 
consumed plants worldwide and has been recognized by its antioxidant potential over the 
years. This activity can protect several diseases with an oxidative stress origin. For these 
reasons, a study was performed to evaluate the quality of information on websites selling 
dietary supplements with green tea. A modified DISCERN tool was used to evaluate 
websites from pharmacies/parapharmacies, websites from food health stores, and 
websites without physical space. Websites scored 1 or 2 at evaluation rating (Low – serious 
or extensive outcomes). These results reveal the importance of developing a checklist for 
the online marketing of herbal products, based on DISCERN instrument, or other. These 
instruments can guide health professionals, who have a very important role in directing 
patients to high-quality sources of information.  
Legal framework for dietary supplements varies among countries, and in Portugal, 
DS are regulated by the Direção Geral de Alimentação e Veterinária (DGAV).  Although there 
are directives published by European Commission, in Portugal, decree-law are incomplete 
and DS safety is placed on the substance’s manufacturer or marketer. In addition, clinical 
trials are not required for DS in Portugal, which allows adulteration, falsification, 
contamination and incorrect labels. In Portugal, DS can be sold in pharmacies, 
parapharmacies, supermarkets, dietetic stores and online, and consumers should be able to 
make informed and appropriate health care choices. Also, consumers use DS labels 
(information provided on the packaging) and leaflets to further their understanding about 
some DS ingredients, relevant indication(s), directions for use, side effects, 
contraindications and drug-supplements interactions. For these reasons, another study 
was performed using an adapted form to evaluate legal and scientific information of twenty 
green tea DS sold in pharmacies, parapharmacies and health food stores in Portugal. From 
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the legal and scientific points of view none of the websites fulfilled all the analyzed criteria. 
Seven DS (35.0%) had indications of use similar to those mentioned in the literature. 
Adverse reactions and drug interactions information were rarely provided by two and three 
DS, respectively.  
Green tea is a complex mixture of several constituents, which include phenolic 
compounds like catechins, flavonoids, and phenolic acids. This chemical composition is 
associated with antioxidant activity. Antioxidant products demand has been increasing 
over the last years. They are referenced as having a protective role in many diseases, like 
cancer, neurodegenerative and cardiovascular disorders. Considering the lack of legislation, 
in Portugal, that controls DS prior to its introduction in the market, the last aim of this thesis 
was to evaluate antioxidant activity of six green tea supplements (three isolated and three 
mixture of substances/plant extracts). This evaluation was performed by common assays, 
namely, DPPH, superoxide and Fe2+ chelating assays. Results showed that antioxidant 
activity depends on composition and concentration of each substance present in green tea’s 
DS. In addition, green tea DS studied showed different antioxidant results at different 
assays performed.  
These thesis results may contribute to understand the importance of quality 
information provided by websites selling DS, and also the importance of regulation 
regarding its manufacturing and selling.   
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Resumo 
 
A utilização de plantas e os seus efeitos benéficos têm sido reconhecidos desde 
sempre. O uso de plantas e, nomeadamente, o consumo de suplementos alimentares à base 
de plantas tem aumentado significativamente nos últimos anos nos Estados Unidos da 
América, bem como na Europa. Além disso, a sua procura e aquisição através de websites 
tem aumentado.  No entanto, vários estudos têm demonstrado que a informação presente 
nestes websites de venda é incompleta, raramente apresenta referências científicas e 
muitas vezes apresenta alegações ilegais. Posto isto, a escolha correta, consciente e 
informada do suplemento por parte do consumidor pode estar comprometida. A planta 
Camellia sinensis, conhecida por chá-verde, é uma das mais consumidas em todo o mundo 
e tem sido reconhecida ao longo dos anos pelo seu potencial antioxidante, estando descrito 
que possibilita a prevenção de inúmeras doenças com origem no stress oxidativo. Deste 
modo, foi desenvolvido um estudo no qual foi avaliada a qualidade da informação 
disponibilizada aos consumidores nos websites de venda de suplementos alimentares 
contendo chá verde. Essa avaliação foi efetuada em websites de farmácias e 
parafarmácias, ervanários, lojas de dietética e lojas sem espaço físico recorrendo a uma 
versão modificada do instrumento DISCERN. Os trinta websites avaliados obtiveram score 
1 ou 2 (baixo resultado). Os resultados obtidos demonstram a necessidade de utilizar/criar 
uma checklist para a venda de suplementos alimentares. Esta pode ser baseada no 
DISCERN ou noutro instrumento semelhante. Estes instrumentos funcionarão como um 
guia para os profissionais de saúde, de modo a direcionar e fornecer aos consumidores 
informações de qualidade.  
A regulamentação de suplementos alimentares varia conforme os países e cidades, 
e em Portugal os mesmos são regulamentados pela Direção Geral de Alimentação e 
Veterinária (DGAV). Apesar da existência de directivas europeias, os decretos-lei que 
regem os suplementos alimentares em Portugal são incompletos e a responsabilidade da 
sua qualidade é conferida ao seu fabricante ou produtor. Em adição, ensaios clínicos não são 
obrigatórios o que facilita adulterações, falsificações, contaminações e existência rótulos 
errados. Em Portugal, os suplementos são vendidos em farmácias, parafarmácias, 
supermercados, lojas dietéticas, ervanários e online. Deste modo, os consumidores devem 
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ter acesso a informações de qualidade para que a sua decisão seja consciente e segura. 
Além disso, os consumidores recorrem à cartonagem/rotulagem e a folhetos informativos 
de suplementos alimentares para obter informações acerca dos seus ingredientes, 
indicações de uso, efeitos adversos, contraindicações e interações. Posto isto, um estudo 
foi desenvolvido com base num formulário adaptado de modo a avaliar as questões legais 
e científicas presentes em vinte suplementos, contendo chá verde, vendidos em farmácias, 
parafarmácias e lojas dietéticas, em Portugal. Do ponto de vista legal e científico nenhum 
dos websites analisados cumpriu todos os critérios analisados. Sete suplementos 
alimentares (35,0%) referiram indicações de uso semelhantes às mencionadas na 
literatura. As informações relativas aos efeitos adversos e às interações com fármacos 
raramente estavam presentes, surgindo em dois e três suplementos, respetivamente. 
O chá verde é uma mistura complexa, contendo compostos fenólicos como as 
catequinas, flavonóides e ácidos fenólicos. Esta composição está intimamente relacionada 
com a sua atividade antioxidante. A procura de produtos antioxidantes tem aumentado nos 
últimos anos. Estes apresentam propriedades preventivas em diversas doenças, como o 
cancro, doenças neurodegenerativas e cardiovasculares. Devido à legislação em vigor em 
Portugal para os suplementos alimentares, estes são colocados no mercado sem passarem 
por um controlo de qualidade obrigatório. Desta forma, o objetivo de outro trabalho incluído 
na dissertação foi a avaliação da atividade antioxidante de seis suplementos de chá verde 
(três suplementos com apenas chá verde como ingrediente ativo e três suplementos com 
mistura de outras substâncias/extratos de plantas). Esta avaliação foi realizada através de 
ensaios comummente utilizados, nomeadamente, o ensaio do radical DPPH, do radical 
superóxido e o ensaio da quelação do ferro (Fe2+). Os resultados demonstraram que a 
atividade antioxidante depende da composição e concentração das substâncias/extratos 
presentes nos suplementos. Além disso, os resultados demonstraram que os suplementos 
apresentaram resultados distintos conforme o ensaio realizado. 
Os resultados desta tese contribuem para uma melhor compreensão da importância 
da qualidade da informação disponibilizada em websites que vendem suplementos 
alimentares, e também da regulamentação de suplementos alimentares em Portugal, 
relativamente ao seu fabrico e comercialização.  
 
 
Dietary supplements with green tea marketed in Portugal: information on websites, labels and antioxidant activity 
 
VIII 
 
Index 
Acknowledgements .................................................................................................................................... III 
Abstract ........................................................................................................................................................... IV 
Resumo ........................................................................................................................................................... VI 
Index ……………………………………………………………………………………………………………………………………………………..VIII 
Abbreviations and Symbols ...................................................................................................................... XI 
List of figures .............................................................................................................................................. XIII 
List of tables ................................................................................................................................................ XIV 
CHAPTER I: General introduction .............................................................................................................. 1 
1.1. Dietary supplements ..................................................................................................................... 2 
1.1.1. Worldwide Consumption --------------------------------------------------- 2 
1.1.2. Legal Framework ---------------------------------------------------------- 3 
1.1.3. Online Market ------------------------------------------------------------- 5 
1.1.4. Green Tea [Camellia Sinensis (L.) O. Kuntze] ---------------------------------- 6 
1.1.4.1. Chemical Composition ...................................................................................................................................... 7 
1.1.4.2. Absorption and Metabolism of Catechins......................................................................................... 9 
1.1.4.3. Pharmacological Actions of Green Tea ............................................................................................ 10 
1.1.4.3.1. Anticarcinogenic Effects ................................................................................................................................ 10 
1.1.4.3.2. Anti-inflammatory Effects............................................................................................................................ 10 
1.1.4.3.3. Antimicrobial Effects ........................................................................................................................................ 11 
1.1.4.3.4. Antioxidant Effects ........................................................................................................................................... 11 
1.1.4.4. Therapeutic Uses of Green Tea ................................................................................................................... 12 
1.1.4.4.1. Overweight/Obesity and Diabetes ........................................................................................................... 12 
1.1.4.4.2. Cardiovascular Diseases ............................................................................................................................... 13 
1.1.4.4.3. Neurodegenerative Diseases ...................................................................................................................... 13 
1.1.4.4.4. Oral health ........................................................................................................................................................... 14 
1.1.4.5. Toxicity ........................................................................................................................................................... 14 
1.1.4.6. Posology ........................................................................................................................................................ 16 
1.2. Oxidative stress and antioxidant defenses .............................................................................. 17 
1.2.1. Endogenous and exogenous antioxidant defenses---------------------------------- 18 
1.2.2. Antioxidant Activity and Green tea ------------------------------------------------ 20 
Dietary supplements with green tea marketed in Portugal: information on websites, labels and antioxidant activity 
 
IX 
 
References ---------------------------------------------------------------------- 24 
CHAPTER II: Quality of information on websites selling dietary supplements with green tea 
……………. ………………………………………………………………………………………………………………………………………………………32 
Abstract------------------------------------------------------------------------- 33 
Introduction --------------------------------------------------------------------- 34 
Methods ------------------------------------------------------------------------ 35 
Results ------------------------------------------------------------------------- 37 
Discussion ---------------------------------------------------------------------- 39 
Conclusion ---------------------------------------------------------------------- 41 
References ---------------------------------------------------------------------- 42 
Annex I ……………………………………………………………………………………………………………………………………………………..44 
CHAPTER III: Dietary supplements with green tea marketed in Portugal and labelling 
information assessment .......................................................................................................................... 50 
Abstract-------------------------------------------------------------------------- 51 
Introduction --------------------------------------------------------------------- 52 
Methods ------------------------------------------------------------------------ 53 
Results ------------------------------------------------------------------------- 54 
Discussion ---------------------------------------------------------------------- 61 
Conclusion ---------------------------------------------------------------------- 65 
References ---------------------------------------------------------------------- 66 
Annex I ……………………………………………………………………………………………………………………………………………………..69 
CHAPTER IV: Antioxidant activity of dietary supplements with green tea marketed in 
Portugal ..........................................................................................................................................................70 
Abstract-------------------------------------------------------------------------- 71 
Introduction --------------------------------------------------------------------- 72 
Methods ------------------------------------------------------------------------ 73 
Results ------------------------------------------------------------------------- 76 
Dietary supplements with green tea marketed in Portugal: information on websites, labels and antioxidant activity 
 
X 
 
Discussion ---------------------------------------------------------------------- 77 
Conclusion ---------------------------------------------------------------------- 81 
References ---------------------------------------------------------------------- 82 
CHAPTER V: General conclusion ........................................................................................................... 86 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dietary supplements with green tea marketed in Portugal: information on websites, labels and antioxidant activity 
 
XI 
 
Abbreviations and Symbols 
 
 
List of abbreviations 
 
ABTS  2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) 
AKT  Protein Kinase B 
AMPK  Activated Kinase AMP protein 
BBB  Blood Barrier Brain  
CAT  Catalase 
CLA  Conjugated Linoleic Acid 
CYP  Cytochrome P450 
DGAV  Direção Geral de Alimentação e Veterinária  
DPPH  2,2-diphenyl-1-picrylhydrazyl 
DRI  Daily Reference Intake 
DS  Dietary Supplement  
DSHEA  Dietary Supplements Health Education Act 
EC  Epicatechin 
ECG  (-)-epicatechin-3-gallate 
EDTA  Ethylenediaminetetraacetic Acid 
EFSA  European Food Safety Authority 
EGC  (−)epicatechin gallate 
EGCG  (−)-epigallocatechin gallate  
EU  European Union  
FDA  Food and Drug Administration  
FRAP  Ferric Reducing Ability of Plasma  
GI  Gastrointestinal 
GSH  Glutathione 
GSH-Px Glutathione peroxidase 
IC50  Half maximal inhibitory concentration 
IL  Interleukin 
INFARMED Autoridade Nacional do Medicamento e Produtos de Saúde, I.P. 
LDL  Low-Density Lipoprotein 
Dietary supplements with green tea marketed in Portugal: information on websites, labels and antioxidant activity 
 
XII 
 
MAO  Monoamine Oxidase 
NADH  Nicotinamide Adenine Dinucleotide 
NADPH Nicotinamide Adenine Dinucleotide Phosphate 
NAOPH Sodium phenoxide 
NBT  Nitro-Blue Tetrazolium 
NF-kB  Nuclear Factor Kappa-B 
NPHs  Natural Health Products 
PMS  Phenazine methosulfate 
RNS  Reactive Nitrogen Species 
ROS  Reactive Oxygen Species 
SMCs  Skeletal Muscle Cell 
SOD  Superoxide dismutase 
TGM’s  Complex based on the Activation of Transglutaminase 
US  United Sates 
 
List of symbols 
H2O2  Hydrogen Peroxide 
NO•  Nitric Oxide 
1O2  Singlet Oxygen 
O2•-  Superoxide Anion 
O3  Ozone 
OH•   Hydroxyl Radical 
ROO˙  Peroxyl Radical 
 
 
 
 
 
 
 
Dietary supplements with green tea marketed in Portugal: information on websites, labels and antioxidant activity 
 
XIII 
 
List of figures 
 
CHAPTER I 
Figure I - Tea extraction processes ...............................................................................................................7 
Figure II - Structures of tea catechins .......................................................................................................... 8 
Figure III - Metabolism of green tea catechins ......................................................................................... 9 
Figure IV - Antioxidant defenses against free radical attack ........................................................... 18 
 
 
CHAPTER II  
Figure I - Overall quality rating of websites selling dietary supplements (DISCERN 
instrument question 16) ………………………………………………………………………………………………………………...…... 52 
Figure II - Quality ratings for the 30 websites per DISCERN instrument question 
(average)…………………………………………………………………………………………………………………………………………………..53 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dietary supplements with green tea marketed in Portugal: information on websites, labels and antioxidant activity 
 
XIV 
 
List of tables 
 
CHAPTER I 
Table I - Studies regarding the evaluation of in vitro antioxidant activity of green tea, in the 
last 10 years. ......................................................................................................................................................... 21 
 
 
CHAPTER II 
Table I - Overall quality rating of websites selling dietary supplements per category 
(DISCERN instrument question 16) ……………………………………………………………………………………………………52 
 
 
CHAPTER III 
Table I - Composition of DS analyzed ………………………………………………………………………………….……………70 
Table II - Topics for evaluation criteria according to legal view for the twenty DS 
………………………………………………………………………………………………………………………………………………………………..…...73 
Table III - Topics for evaluation criteria according to scientific view for the twenty DS 
……………………………………………………………………………………………………………………………………………………………….…....74  
Table IV- Adverse effects, contraindications/precautions of use and interactions present in 
single- ingredient vs multi-ingredient twenty green tea DS …………………………………….……………..….76  
 
 
CHAPTER IV 
Table I - Composition of study samples ……………………………………………..…………………………………………...89  
Table II - IC50 results for six samples in DPPH antioxidant, Super oxide and Iron-chelating 
activity assays ………………………………………………………………………………………………………………………………………..93  
Table III - IC50 results for positive control ……………………………………………….………………………………………94  
 
 
 
 
XV 
 
 
1 
 
 
 
 
 
 
 
 
  
 
 
 
 
General Introduction 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER I 
Dietary supplements with green tea marketed in Portugal: information on websites, labels and antioxidant activity 
 
2 
 
1.1. Dietary Supplements 
 
1.1.1. Worldwide Consumption 
  
The use of plants and their health benefits have been recognized over the years and 
continues to expand rapidly across the world (Cunha et al., 2012). It is estimated that in 
Europe, North America and other industrialized regions, more than 50% of the population 
has already used medicinal plants as a complementary and/or alternative medicine at least 
once (Santos et al., 2008). Thus, in developed countries up to four billion people (about 80% 
of global population) rely on herbal medicinal products as primary source of wellness 
(Bodeker, 2005). As the global use of herbal medicinal products continues to grow and 
newer products are introduced into the market, public health issues, and concerns 
surrounding their safety are also increasingly recognized (Ekor, 2014). 
DS are defined as concentrated sources of nutrients or other substances with a 
nutritional or physiological effect that increase the overall dietary intake by supplementing 
the normal diet (Decreto-Lei n. º 136/2003). They are marketed in measured doses (e.g., as 
pills, tablets, capsules, liquids) (Decreto-Lei n. º 136/2003). 
The use of DS is widespread, and can be influenced by a number of factors such as 
gender, age, educational level, socio-economic status, place of residence, and ethnicity. 
Prevalence data on the regular use of DS by general population over the last two decades 
are available for several countries. The consumption of DS has increased in the last years in 
United States (US) and Europe (Assena, 2010; Bailey et al., 2011; De Smet, 2005). The 
consumption values of DS vary between 22% and 53% in the US (Bailey et al., 2011), Canada 
(Shakur, Tarasuk, Corey, & O'Connor, 2012), Korea (Lee & Kim, 2009), United Kingdom 
(Lentjes, Welch, Keogh, Luben, & Khaw, 2015), Sweden (Messerer, Johansson, & Wolk, 
2001), Germany (Li, Kaaks, Linseisen, & Rohrmann, 2010) and France (Pouchieu et al., 
2013). Studies in Portugal, despite scarce (Felício, 2006),  follow this world tendency.  For 
example, a study about DS consumption by Portuguese population concludes that 81% of 
participants consume or have already consumed DS (38% as teas/infusions/plants) 
(Fernandes, 2012). Another national study showed that 48% of the participants in Lisboa 
and Região do Vale do Tejo consumed herbal medicines or herbal supplements (Santos et 
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al., 2008). DS consumption represents a high globally growing market (in 2016 represented 
132.8 billion USD) (Zion Market Research, 2017).  
The resurgence of public interest in herbal medicines, including DS, has been 
attributed to several factors some of which include: i) preference to a healthy lifestyle (e.g., 
for the improvement of physical performance); (ii) various claims on the efficacy or 
effectiveness of plant medicines; (iii) the belief that these products might be effective in the 
prevention and treatment of certain diseases where conventional therapies have proven to 
be ineffective or inadequate; (iv) side effects of most modern drugs; (vi) improvements in 
the quality, efficacy, and safety of herbal medicines with the development of science and 
technology, and (viii) a movement toward self-medication (Bailey, Gahche, Miller, Thomas, 
& Dwyer, 2013; Dickinson & MacKay, 2014). 
 
1.1.2. Legal Framework 
 
The legal framework for supplements varies among countries, even when they have 
similar cultures, legal systems, and levels of economic development (Chow et al., 2005). For 
example, in Brazil, the category “dietary supplement” does not exist, and these products are 
placed in other food categories such as food for athletes, vitamins and/or mineral 
supplements, and foodstuffs with functional properties or health claims (da Justa Neves & 
Caldas, 2015). The distinction between foodstuffs and medicinal products is also clear in the 
European Union (EU) (European Parliament, 2004), although there are the so-called 
“borderline products”, which contain substances that may have pharmacological effects at 
a given dose (Lachenmeier & Rehm, 2012). In the US, DS are regulated under the Dietary 
Supplements Health Education Act (DSHEA) of 1994 as a subset of foods and limited to 
those taken orally. Manufacturers must hold evidence to support their claims and they 
cannot make specific disease treatment claims, but only those are related to nutritional 
support. All products must carry a disclaimer on the label stating that claims have not been 
reviewed by the US Food and Drug Administration (FDA) (U.S Food & Drug Administration, 
2018). In Canada, the majority of these DS are referred to as natural health products (NHPs) 
and are considered a subset of drugs under a specific set of regulations - the Natural Health 
Products Regulations. Products must undergo a premarket assessment for safety, quality 
and efficacy (Government of Canada, 2018).  
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In the EU some steps were taken, in order to harmonize the regulation of nutritional 
supplements, health foods, and herbal medicines. For that reason, the European 
Commission has published directives regulating food supplements (2002/46/EC) and 
herbal remedies (2004/24/EC and 2004/27/EC) (European Parliament, 2002, 2004). 
The Directive 2002/46/EC was implemented to safeguard human health, because in some 
cases excessive intake of vitamins and minerals may be harmful or cause unwanted side 
effects; therefore, maximum levels are necessary to ensure their safe use in food 
supplements (European Parliament, 2002). A very important piece of legislation for the 
food supplements sector is Regulation (EC) No. 1924/2006 on nutrition and health claims. 
According to this regulation, health claims must be based on and substantiated by generally 
accepted scientific evidence and must not mislead the consumer (European Parliament, 
2006). They need to be authorized by the European Commission and member states under 
the scrutiny of the European Parliament and Council following an assessment of their 
scientific substantiation by the European Food Safety Authority (EFSA) (European 
Parliament, 2006; Quintus & Schweim, 2012).  
In Portugal, DS are regulated by Direção Geral de Alimentação e Veterinária (DGAV) 
and according to the Decree-Law No. 136/2003, of 28 June, these products are defined as 
“concentrated sources of nutrients or other substances with a nutritional or physiological 
effect, marketed in dose form, with the purpose of supplementing the normal diet” (Decreto-
Lei n. º 136/2003). According to Decree-Law No. 136/2003, of 28 June and Decree-Law 
No. 118/2015, of 23 June the labeling for DS must contain the following requirements: (i) the 
names of nutrients categories or substances that characterize the product or an indication 
of the nature of those nutrients or substances; (ii) the recommended daily dose; (iii) warning 
for daily intake should not be exceeded; (iv) a declaration to the effect that the supplement 
is not a substitute for a varied diet; (v) warning to keep out of reach of children. In addition, 
the DS labelling must not contain: (i) any statement attributing to the product properties of 
preventing, treating, or curing a human disease; and (ii) any mention stating or implying that 
a balanced and varied diet cannot provide appropriate quantities of nutrients in general 
(Decreto-Lei n. º 136/2003; Decreto-Lei n. º 118/2015). 
Most of the problems associated with the use of traditional and herbal medicines 
arise mainly from the classification of many of these products as foods or DS in some 
countries. As such, evidence of quality, efficacy, and safety of these products is not required 
Dietary supplements with green tea marketed in Portugal: information on websites, labels and antioxidant activity 
 
5 
 
before marketing (Ekor, 2014). Clinical trials are not required for DS in Portugal, which may 
promote adulteration, falsification, contamination and incorrect labels. In Portugal, these 
products can be sold in pharmacies, supermarkets, dietetic stores and over the internet. 
Therefore, the safety of DS is an important issue nowadays.  
 
1.1.3. Online Market 
 
Despite their popularity, the benefits of DS in general population are equivocal 
(Harvey, Korczak, Marron, & Newgreen, 2008; Timbo, Ross, McCarthy, & Lin, 2006). 
However, risks associated with dietary supplementation are also well documented, and 
include contamination, inadvertent outcomes and side effects. Furthermore, promotion of 
supplements may include misleading nutrition labels and health claims (Kwan D, 2009).  
The internet is an important source of information for all themes, including health 
topics (Cooke & Gray, 2002). The Internet is not only used by consumers for the purchase 
of medicines and DS, but also for searching of health related information (60% of 
Europeans, 57% of the US population) (European Parliament, 2002; Wolters Kluwer Health, 
2012). Consumers that use Internet to access health information and purchase DS are 
increasing (Thakor, Leach, Gillham, & Esterman, 2011). The difficulty for consumers and 
health professionals is identifying websites that provide reliable information (Saldanha et 
al., 2010).  
According to the Wolters Kluwer’s study from 2012, 65% of respondents in the US 
trusted the information presented on the Internet (Wolters Kluwer Health, 2012). However, 
more than 90% of websites contain no warning against possible supplement-drug 
interactions, adverse reactions, or suitability of use of the DS in children or during pregnancy. 
In addition, labeling, safety, and efficacy information is not required to be posted on 
websites selling DS, although its presence would be beneficial for the consumer to make 
informed purchasing decisions (Jordan & Haywood, 2007). 
Several studies showed that information on most websites is incomplete, poorly 
referenced and many included illegal claims (Jordan & Haywood, 2007; Thakor et al., 2011). 
Also, many commercial websites containing food and supplement composition data link to 
a common source and do not contain original information themselves, so there is no 
guarantee that the information they provide is valid (Saldanha et al., 2010). The presentation 
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of misleading information represents a serious problem, because most of DS are purchased 
without clinician’s prescription, and many patients do not report their use (Thakor et al., 
2011). Of related concern, is the misperception among some consumers that herbal 
medicines are natural, safe and without risk. Besides that, this online selling method is fast 
and uncontrolled, with daily updates. So, its oversight is impossible in any country (Schmidt, 
2002). Given the magnitude and amount of health information on websites and its impact 
on health care decisions, it is important to analyze and regulate the quality of information. 
What is also unclear is whether the type of website (e.g. pharmacy, parapharmacy, health 
food store) has any influence on the quality of information presented. 
 
1.1.4. Green Tea [Camellia Sinensis (L.) O. Kuntze] 
 
Tea is made from leaves of Camellia Sinensis (Theaceae family) and is one of the 
most consumed beverages worldwide (Cunha et al., 2012). It is estimated that about 2.5 
million tons of tea are produced each year in the world, with 20% produced as green tea and 
mainly consumed in Asia and the Middle East (Chacko, Thambi, Kuttan, & Nishigaki, 2010).  
The tea plant is believed to have originated in the Southeast Asia (Singhal, Raj, 
Gupta, & Singh, 2017) and is cultivated in more than 30 countries, including India, China, Sri 
Lanka, Kenya, Indonesia, Turkey, former Soviet Union, Japan, Iran, Bangladesh, Malawi, 
Vietnam, and Argentina (Cooper, Morre, & Morre, 2005).  
There are at least four types of tea, based on the distinct processing techniques 
used for each type: white, green, oolong, and black tea (Dostal et al., 2015). Black tea is the 
major form of tea consumed worldwide and constitutes 78% of the world’s tea production. 
It is produced by crushing tea leaves to allow the release polyphenol oxidase enzyme. This 
enzyme catalyzes the oxidation of tea catechins and as a consequence, catechins are 
oxidized and condensed to polymeric polyphenols (thearubigins) and oligomeric 
polyphenols (theaflavins), which are responsible for the color and flavor characteristics of 
black tea. Green tea is produced from more mature leaves which are steamed or heated 
immediately after harvest to minimize oxidation reactions; white tea is processed the least 
and uses very young leaves and leaf buds; and oolong tea is made by crushing only the rims 
of the tea leaves and ‘fermented’ under tightly controlled conditions (Botten, Fugallo, 
Fraternali, & Molteni, 2015; Reygaert, 2018) (Figure I).  
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Figure I - Tea extraction processes (Cooper et al., 2005).  
 
Among all of the different teas, however, the most significant effects on human 
health have been observed with green tea (Chacko et al., 2010). The plant has preventive 
effects on many diseases, including cardiovascular (Hodgson & Croft, 2010), 
neurodegenerative (Andrade & Assuncao, 2012) and cancer (Yuan, 2013). Also, 
antibacterial, anti-inflammatory, antidiabetic and weight loss activities have been 
associated to green tea (Zaveri, 2006).  
 
1.1.4.1. Chemical Composition 
 
Tea is a complex mixture comprised of several constituents. To produce green tea, 
fresh leaves of the plant are steamed and heating after harvest (Dostal et al., 2015). This 
process minimizes oxidation reactions, which results in high content of polyphenols (Dostal 
et al., 2015), including catechins, flavonoids, and phenolic acids (chlorogenic acid, caffeic 
acid, gallic acid) (Cunha et al., 2012). These compounds represent 25-35% of the dry weight 
(Wang & Lei, 2015).  
Catechins (20-30% of tea dry weight) include: (-)-epicatechin (EC) (≈ 6%), (-)-
epigallocatechin (EGC) (≈ 20%), (-)-epicatechin-3-gallate (ECG) (≈14%), and (-)-
epigallocatechin-3-gallate (EGCG) (Wang & Lei, 2015) (Figure II).  
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Figure II - Structures of tea catechins (Yang & Pan, 2012). 
 
EGCG is the most abundant catechin in green tea (≈ 60%) (Bao & Peng, 2016; 
Reygaert, 2018). Green tea contains more catechins than the other teas, mainly because of 
the way it is processed after harvesting (Narotzki, Levy, Aizenbud, & Reznick, 2013). The 
amount of catechins in green tea can also be affected by differences in variety, origin, 
growing conditions, harvesting, and processing conditions (Reygaert, 2018). 
Tea leaves also contain lower quantities of other polyphenols such as quercetin, 
kaempferol, and myricetin as well as alkaloids, such as caffeine and theobromine. One cup 
of green tea (with 2.5 g of tea leaves brewed for 3 min in 250 ml hot water) usually contains 
about 300 - 400 mg of polyphenols (130 – 180 mg of EGCG) and between 50 and 100 mg 
of caffeine (Singhal et al., 2017). In addition, green tea has proteins (mainly enzymes) (15%), 
carbohydrates (cellulose, pectins, glucose, fructose, sucrose) (5%), lipids (linoleic and 
linolenic acids), vitamins (B, C and E), pigments (chlorophyll and carotenoids), mineral and 
trace elements (4-9%) and volatile compounds (0.1%) (Cunha et al., 2012). 
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1.1.4.2. Absorption and Metabolism of Catechins 
 
In order to be effective in the body, catechins present in green tea need to be 
bioavailable after consumption. The bioavailability of tea polyphenols is dependent on the 
molecular size and number of phenolic groups. Only a small fraction of tea catechins present 
in the intestinal tract after drinking tea can be absorbed, and therefore considered to be 
bioavailable (Cai et al., 2018). Once in the body, catechins undergo metabolic processing in 
the liver and small intestine and colon (Reygaert, 2018). After tea consumption, they 
undergo Phase II and III metabolism in enterocytes or hepatocytes and exerted from bile, 
feces and urine. Catechins and their conjugated metabolites, catabolized small molecular 
phenolic acids can be distributed in various organs and tissues, where they perform various 
biological actions (Warden, Smith, Beecher, Balentine, & Clevidence, 2001) (Figure III).  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure III - Metabolism of green tea catechins (Cai et al., 2018). 
 
The levels of catechins peak concentrations are affected by an individual’s 
metabolism and of course by the amount of catechins in the ingested type of green tea 
(Reygaert, 2018). The peak concentrations of catechins and their metabolites occur in blood 
plasma between 1.5 and 2 hours after ingestion and in urine between 4 and 6 hours after 
ingestion (Reygaert, 2018). Some studies showed that approximately 1.68% of catechins 
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were present in human’s plasma (0.16%), urine (1.1%) and feces (0.42%) after tea ingestion 
over 6 hours (Cai et al., 2018). Generally, the levels found in the body are directly proportional 
to the amount of catechins consumed (Clifford, van der Hooft, & Crozier, 2013).  
 
1.1.4.3. Pharmacological Actions of Green Tea 
  
Nowadays green tea has been studied for its potential beneficial health effects 
(Yang, Wang, & Sheridan, 2018). The plant has been shown to have anticarcinogenic, anti-
inflammatory, antimicrobial, and antioxidant properties (Reygaert, 2018). 
 
1.1.4.3.1. Anticarcinogenic Effects 
 
Polyphenols present in green tea promote anticarcinogenic effect. Many studies 
report that tea polyphenols inhibited the formation and development of tumors at different 
organ sites, in animal models (Yang, Wang, Lu, & Picinich, 2009). Various molecular targets 
of EGCG in cancer therapy are the molecules and pathways involved in cell survival and 
growth (Gaur & Agnihotri, 2014). In fact, catechins control cellular proliferation factors; 
apoptosis (by augmenting the expression of apoptotic protein expression, namely p53 and 
p21) and angiogenesis in tumor cells; oxidative stress; NF-κB signaling; pro-inflammatory 
cytokines; cell cycle; metastasis related enzymes; and suppress the expression of the 
prostate specific antigen and androgen receptor transcriptional activity (Pandey, Shukla, & 
Gupta, 2010; Shirakami, Sakai, Kochi, Seishima, & Shimizu, 2016).  
 
1.1.4.3.2. Anti-inflammatory Effects 
 
Tissue injury or exposure to bacterial endotoxins, pro-inflamamtory cytokines, 
mitogens and viral proteins triggers immune-inflammatory reactions, such as the 
arachidonic acid pathway. Furthermore, there is an activation of nuclear factor kappa-B 
(NF-κB), which regulates chronic inflammatory reactions and pro-inflammatory cytokine 
production (Gaur & Agnihotri, 2014; Maroon, Bost, & Maroon, 2010). Inflammation is a 
component of many conditions and diseases including aging, arthritis, cancer, 
cardiovascular diseases, diabetes, and obesity. Green tea polyphenols (especially EGCG) 
reduce nitric oxide (NO) production, an important mediator of inflammation; scavenge 
reactive oxygen species (ROS) formed during the inflammatory process from the damaged 
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cells, thereby downregulating t NF-κB; inhibits pro-inflammatory cytokines, such as 
interleukin (IL)-1β (Gaur & Agnihotri, 2014). 
 
1.1.4.3.3. Antimicrobial Effects 
 
Green’s tea antimicrobial effects are related to catechins (Reygaert, 2018). It  blinds 
bacterial cells membrane, which interferes with various bacterial processes and can 
damage cell strains (Steinmann, Buer, Pietschmann, & Steinmann, 2013). Green tea has the 
capacity to diminish bacterial’s ability to bind to host cells (Reygaert, 2018) and inhibits the 
ability of the bacteria to bind to each other to form biofilms, which are significant in 
pathogenesis (Blanco, Sudano-Roccaro, Spoto, Nostro, & Rusciano, 2005). In addition, 
damage to the cell membrane also results in loss of function to transmembrane transporter 
proteins, which are responsible for secretion of toxins and efflux of substance such as 
antimicrobial agents (Nakayama et al., 2015). Green tea extracts possess antimicrobial 
activity against the methicillin-resistant Staphylococcus aureus (MRSA), Clostridium 
botulinum, Bacillus cereus, Escherichia coli, Klebsiella pneumonia and Salmonella  (Saeed et 
al., 2017; Yoda, Hu, Zhao, & Shimamura, 2004). Also, against Helicobacter pylori, viruses 
(e.g. hepatitis, HIV, rota-, entero- and influenza virus), yeasts, filamentous fungi, Chlamydia, 
mycoplasmas and parasites (Taylor, Hamilton-Miller, & Stapleton, 2005).  
 
1.1.4.3.4. Antioxidant Effects 
 
 Green tea has the ability to directly scavenge Reactive oxygen species (ROS) 
(including superoxide, hydroxyl radical and hydrogen peroxide), it inhibits the redox 
sensitive transition metal ions and transcription factors, pro-oxidant enzymes, and induce 
antioxidant enzymes (Xiang et al., 2016). Green tea is rich in antioxidants and its activity are 
well documented (Saeed et al., 2017). The imbalance between ROS and antioxidants results 
in oxidative stress, responsible for cellular damage (Saeed et al., 2017). Catechins in green 
tea increase serum superoxide dismutase activity and aorta catalase enzyme and have a 
protective role against oxidative stress (Chacko et al., 2010). In vitro antioxidant activity 
assessment methods are often used to screen and confer antioxidant potential to plants or 
their phytochemicals and sometimes to understand the probable mechanism of action of 
plant antioxidants (Foyer & Noctor, 2005). Green tea antioxidant activity can be also 
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revealed by ferric reducing ability of plasma (FRAP) and 2,2-diphenyl-1-picrylhydrazyl 
(DPPH) scavenging assays (Langley-Evans, 2000; Nanjo et al., 1996). Green tea, especially 
EGCG, may exert its beneficial effects by modulation of mitochondrial functions, alteration 
of the cell cycle, and mitochondria-related apoptosis (Oliveira et al., 2016).  
 
1.1.4.4. Therapeutic Uses of Green Tea 
 
Research into the effects of green tea on human health has shown that it can be an 
important dietary factor in the prevention and treatment of various diseases such as 
arthritis, cancer, cardiovascular diseases, diabetes and obesity, infections, and in neurologic 
and oral health (Reygaert, 2014). 
 
1.1.4.4.1. Overweight/Obesity and Diabetes 
 
Overweight, obesity and diabetes are emerging as major global health issues, and 
the closely related metabolic syndrome also predisposes individuals to cardiovascular 
diseases (Yang, Zhang, Zhang, Huang, & Wang, 2016). Increasing evidence shows that 
obesity is associated with insulin resistance, chronic low-grade inflammatory responses, 
and oxidative stress (Suliburska et al., 2012). Obesity is a result of an increase in fat mass 
which is caused by increase in the size of fat cells (Reygaert, 2018). Green tea has been 
shown results in these cases by decreasing absorption of lipids and proteins, thus reducing 
calorie intake. The plant also interferes with activated kinase AMP protein (AMPK) by tea 
polyphenols that are bioavailable in the liver, skeletal muscle, and adipose tissues; 
decreases gluconeogenesis and fatty acid synthesis; and increases catabolism  (Yang et al., 
2016). These mechanisms also decreased total plasma and LDL (low-density lipoprotein) 
cholesterol, triglycerides, and blood pressure (Suzuki, Pervin, Goto, Isemura, & Nakamura, 
2016). All these actions have an important role in obese and/or diabetic people (Grandl & 
Wolfrum, 2018; Iqbal, Al Qarni, Hawwari, Alghanem, & Ahmed, 2018). Clinical physiology 
studies show that diminished insulin-stimulated vasodilation is consistently in subject with 
obesity and/or diabetes (Munir, Chandrasekaran, Gao, & Quon, 2013). This insulin 
resistance is associated to type 2 diabetes and in some cases the insulin production is also 
affected (Munir et al., 2013). In this metabolic disorder green tea has been shown to increase 
insulin receptor sensitivity and stimulate glucose-induced insulin secretion (Fu et al., 2017). 
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Thereafter the positive effects of green tea supplementation have been observed 
particularly in the prevention and control of type 2 diabetes (Harrison et al., 2011).  
 
1.1.4.4.2. Cardiovascular Diseases 
 
Several studies suggest that catechins prevent the incidence of detrimental 
cardiovascular events, and also lower the cardiovascular mortality rate (Bhardwaj & 
Khanna, 2013). Studies have shown that green tea polyphenols have favorable effects on 
systemic risk factors and direct effects on the vasculature and platelets that might account 
for reduced cardiovascular risk (Deka & Vita, 2011; Kushiyama, Shimazaki, Murakami, & 
Yamashita, 2009; Nakachi, Matsuyama, Miyake, Suganuma, & Imai, 2000). Green tea has 
the ability to prevent atherosclerosis, hypertension, endothelial dysfunction, ischemic heart 
diseases, cardiomyopathy, cardiac hypertrophy and congestive heart failure by decreasing 
oxidative stress, preventing inflammatory events, and reducing platelet aggregation 
(Bhardwaj & Khanna, 2013). Additionally, they interfere with vascular growth factors, which 
inhibit vascular smooth muscle cell proliferation and thrombogenesis by suppressing 
platelet adhesion; could protect vascular endothelial cells and enhance vascular integrity 
and regulate blood pressure (Bhardwaj & Khanna, 2013). All these documented 
mechanisms indicate the positive effects of green tea in the prevention and treatment of 
cardiovascular diseases (Kuriyama et al., 2006). 
 
1.1.4.4.3. Neurodegenerative Diseases 
 
Green tea has been found useful against neurodegenerative diseases such as 
Alzheimer’s disease, and Parkinson’s disease (Saeed et al., 2017). EGCG inhibits apoptosis 
in some neurons and prevents neurotoxicity caused by β-amyloid in neuronal hippocampus 
cells (Mancini et al., 2017; Saeed et al., 2017). In addition, EGCG also prevented the lesions 
caused by Parkinson’s disease (Levites, Amit, Youdim, & Mandel, 2002). The anti-
inflammatory and antioxidant properties of green tea also protect neurons, and green tea 
metabolites have been shown to cross the BBB (blood brain barrier) (Faria et al., 2011). When 
flavonoids cross the BBB, they can control molecular traffic and buffer against changes in 
the systemic circulation (Faria et al., 2011). 
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1.1.4.4.4. Oral health 
 
Oral health represents another green tea prevention area. Numerous studies have 
suggested beneficial effects of green tea on oral conditions such as dental caries, 
periodontal diseases and halitosis (Khurshid, Zafar, Zohaib, Najeeb, & Naseem, 2016). It has 
been shown that catechins increase the activity of oral peroxidases, preventing the 
development and progression of periodontitis, and reducing dentin erosion and tooth loss, 
and it has also a role in improving bad breath (Kushiyama et al., 2009).  
The beneficial role of fluoride, present in green tea, is well known as it inhibits 
bacterial growth and helps remineralization of dental tissues (Zafar, 2015). Also, green tea 
can abolish bad breath by suppressing anaerobic bacteria and eliminating the production of 
volatile sulfur compounds, responsible for halitosis (Rassameemasmaung, Phusudsawang, 
& Sangalungkarn, 2013). Periodontal health is inversely related to green tea consumption 
(Koyama et al., 2010). Green tea plays a supportive role in the maintenance of periodontal 
health, where EGCG can restrict the development and colonization of harmful bacteria such 
as Porphyromonas gingivalis, Prevotella intermedia, and Prevotella nigrescens  (Makimura 
et al., 1993).  
 
1.1.4.5. Toxicity 
 
Bioavailability is a factor positively associated with the severity of green tea’s 
catechins toxicity. For example, fasting increases EGCG bioavailability (Chow et al., 2005) 
leading to increased severity of adverse effects when consumed on an empty stomach. 
Also, the risk of adverse effects is likely increased by factors that increase the bioavailability 
of these flavanols such as genetic polymorphisms in metabolizing enzymes (Miller et al., 
2011) and herb-drug interactions.   
A number of plant extracts are recognized as posing a drug interaction liability when 
combined with conventional therapeutics (Albassam & Markowitz, 2017). Green tea has 
various bioactive compounds that are absorbed, metabolized and eliminated similar to 
many drugs. Therefore, possible interactions between tea constituents and drugs as 
competitive substrates or inhibitors are expected. Tea catechins may directly bind to drugs 
and decrease their absorption, bioavailability and their biological activities. Tea catechins 
may also increase or decrease the expression (or activities) of drug-metabolizing enzymes 
and drug transporters (Yang & Pan, 2012). 
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At modest consumption levels, green tea generally appears unlikely to result in 
clinically significant effects on the disposition of drugs metabolized by cytochrome P450 
(CYP) enzymes (Albassam & Markowitz, 2017). In fact, it can inhibit or promote drug 
absorption or elimination by interacting with intestinal and hepatic organic anion transport 
peptides responsible for drug absorption from the intestinal lumen and bloodstream 
removal (Kim et al., 2017).  
Green tea has antioxidant properties, and when some compounds with antioxidant 
properties are combined, different interactions may occur showing various effects that may 
be synergistic, antagonistic or additive (Ranjbar Nedamani, Sadeghi Mahoonak, Ghorbani, & 
Kashaninejad, 2015). Several studies have reported adverse effects related to green tea, 
and most of 50% were considered sufficiently documented for causality assessment 
(Pittler, Schmidt, & Ernst, 2005; Shaw, Leon, Kolev, & Murray, 1997; Valli & Giardina, 2002). 
In general, side-effects were associated with green tea leaves derivates and involved 
mainly with acute hepatotoxicity (Di Lorenzo et al., 2015). The components most frequently 
indicated as responsible for hepatotoxicity are catechins and its gallic esters (Galati, Lin, 
Sultan, & O'Brien, 2006). The hepatotoxicity can be imputed to the capability of EGCG or its 
metabolites to induce oxidative stress in the liver (Mazzanti et al., 2009).  
Caffeine is a methylated xanthine, alkaloid, and an important compound of green tea 
(Colon & Nerin, 2014). In humans, caffeine acts as a central nervous system stimulant. 
However, the excessive can produce negative effects in the organism such as anxiety 
disorders (Colon & Nerin, 2014).  In fact, the concomitant use of green tea and caffeine needs 
an informed supervision. Some drug interactions and/or related problems to caffeine intake 
are: monoamine oxidase (MAO) inhibitors, including furazolidone, procarbazine and 
selegiline. In this case, large amounts of caffeine may produce dangerous cardiac 
arrhythmias or serve hypertension because of caffeine’s sympathomimetic side effects of 
caffeine (Colon & Nerin, 2014). These interactions can be controlled by the amount of 
caffeine intake. The amount of caffeine in tea beverage is determined by the brewing 
conditions of time, temperature, leaf size, and amount of tea (Wiseman, Balentine, & Frei, 
1997). 
Many studies related interactions of green tea with cardiovascular drugs (Werba et 
al., 2018), potentially leading to reduced drug efficacy or increased risk of drug toxicity 
(Catapano et al., 2017). EGCG, ECG, EGC, EC are responsible for these interactions (Werba et 
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al., 2018). These drug interactions reported in humans increased in the last years and now 
include simvastatin, rosuvastatin, nadolol, sildenafil, tacrolimus and warfarin (Catapano et 
al., 2017). Green tea contains vitamin K, which probably promotes the antagonism of 
warfarin by green tea (Catapano et al., 2017). Vitamin K concentration in green tea products 
depends on the dilution and amount of tea leaves used to brew the tea (Catapano et al., 2017; 
Mills et al., 2011). Also, the amount of tea consumed per day will play a major role in 
determining the actual amount of exogenous vitamin K consumption (Catapano et al., 2017; 
Mills et al., 2011). 
Safety and tolerability of green tea’s long-term use has not been well defined (Bun, 
Bun, Guedon, Rosier, & Ollivier, 2006; Teschke, Zhang, Melzer, Schulze, & Eickhoff, 2014). In 
conclusion, the risk of interactions might be higher in patients who consume high volumes 
of green tea and infusions with high catechin content (Werba et al., 2018). The risks 
associated with high dose of green tea are: drinking a large amount may cause neural tube 
birth defect in infants due to folic acid antagonism due to caffeine, catechins and tannic acids 
in green tea; discolors the dental plaque but not the teeth itself; increased bleeding time and 
risk of bladder cancer; stain esthetic restorative material in oral cavity; insomnia, anxiety, 
irritability, nausea and headaches; stomach upset and diuresis; heart irregularities, tremor 
and restlessness (Singhal et al., 2017) . 
There are a few contraindications known associated with green tea consumption. 
Individuals with weakened cardiovascular systems, renal diseases, thyroid hyperfunction, 
elevated susceptibility to spasm, and certain psychic disorders (e.g., panicky states of 
anxiety) should use green tea with caution. Also, green tea’s intake during pregnancy is 
contraindicated. Lactating women should also limit caffeine intake to avoid sleep disorders 
in infants as well as children (Wollschlaeger et al., 2003). 
 
1.1.4.6. Posology 
 
Clinical studies reveal that a regular long-term daily ingestion of tea is safe and 
contributes significantly to the prevention of some diseases; however, the dosage intake is 
depending on clinical situation and desired therapeutic effect (Wollschlaeger et al., 2003). 
 A green tea infusion contains about 300 - 400 mg of polyphenols (Singhal et al., 
2017), depending on the type of tea, harvesting variables, and brewing methods (Yamimoto, 
1997). EMA recommends 1.8-2.2 g of whole or comminuted herbal substance in 100-150 
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mL of boiling water as an herbal infusion, 3-5 times daily (Committee on Herbal Medicinal 
Products, 2013). In case of powered herbal substance, EMA recommends 390 mg 3 times 
daily up to 5 time (Committee on Herbal Medicinal Products, 2013). The use in children and 
adolescents under 18 years of age is not recommended time (Committee on Herbal 
Medicinal Products, 2013). 
 
1.2. Oxidative Stress and Antioxidant Defenses 
 
Radical species or free radicals have one or more unpaired electrons in their valence 
shell. They are produced at low levels during normal physiological conditions and are 
scavenged by endogenous antioxidant systems (Filaire et al., 2013). The harmful effect of 
free radicals causing potential biological damage is termed oxidative stress (Donzelli et al., 
2006; Valko et al., 2007). In fact, oxidative stress results from the metabolic reactions that 
use oxygen and represents a disturbance in the equilibrium status of prooxidant/ 
antioxidant reactions in living organisms (Valko et al., 2007). 
ROS are products of normal cellular metabolism and represent the most important 
class of radical species generated in living organisms (Valko et al., 2007). Chloroplasts and 
mitochondria are the two main powerhouses and sites of ROS generation within plant cell 
(Kasote, Katyare, Hegde, & Bae, 2015). Biologically, significant ROS elements include 
hydroxyl radical (OH•), superoxide anion (O2•-), nitric oxide (NO•), hydrogen peroxide (H2O2), 
ozone (O3), singlet oxygen (1O2), and peroxyl radical (ROO˙) (Aceti, Beghetti, Martini, Faldella, 
& Corvaglia, 2018). 
Oxidative stress results from the overproduction of ROS in the organism that 
exceeds the endogenous antioxidant capacity for them to be eliminated (Sifuentes-Franco, 
Pacheco-Moises, Rodriguez-Carrizalez, & Miranda-Diaz, 2017). ROS imbalance can 
damage cellular lipids, proteins or inhibit DNA normal function (Valko et al., 2007). 
Depending on the type of antioxidants, intensity, and time of redox imbalance as well on the 
type of cells, oxidative stress can influence synthesis of antioxidant enzymes, repair 
processes, promote inflammatory responses and/or affecting immune system, apoptosis, 
cell proliferation and damaging key biomolecules (DNA, membrane lipids, enzymes (D'Arena 
et al., 2018; Kousteni, 2011).  For these reasons, oxidative stress has been implicated in 
several human diseases (Valko et al., 2007). Oxidative stress is involved in several age-
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related conditions (cardiovascular diseases, chronic obstructive pulmonary disease, chronic 
kidney disease, neurodegenerative diseases, and cancer), including sarcopenia and frailty 
(Liguori et al., 2018).  
 
1.2.1. Endogenous and exogenous antioxidant defenses  
 
Exposure to free radicals has led organisms to develop an extensive range of 
antioxidant defenses, both endogenous and exogenous (Filaire et al., 2013). These defenses 
can be modified by exercise, training, nutrition and aging (Dekkers, van Doornen, & Kemper, 
1996) and can be divided into three main groups: antioxidant enzymes, chain breaking 
antioxidants, and transition metal binding proteins (Figure IV).  
 
 
 
Figure IV - Antioxidant defenses against free radical attack (Halliwell & Gutteridge, 1990) 
 
Antioxidant enzymes catalyze the breakdown of free radical species, usually in 
intracellular environment. Transition metal binding proteins prevent the interaction of 
transition metals (e.g. iron and copper) with hydrogen peroxide and superoxide producing 
highly reactive hydroxyl radicals. Chain breaking antioxidants are electron donors and react 
preferentially with free radicals before important target molecules are damaged. 
Antioxidants can be synthesized in vivo or taken as dietary antioxidants (Kasote et 
al., 2015).  Plants have long been a source of exogenous antioxidants (Kasote et al., 2015). 
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They may act as radical scavengers, peroxide decomposers, hydrogen donors, electron 
donors, singlet oxygen quenchers, enzyme inhibitors, or metal-chelating agents (Frei, 
Stocker, & Ames, 1988). Their effect depends on concentration, polarity, medium, and 
presence of other antioxidants (Sifuentes-Franco et al., 2017).  
Antioxidant defense protects biological systems from free radical toxicity and 
includes both endogenous and exogenous molecules (Liguori et al., 2018). Endogenous 
antioxidants include enzymatic and non-enzymatic pathways (Liguori et al., 2018). 
Antioxidant enzymes are superoxide dismutase (SOD), catalase (CAT), glutathione 
peroxidase (GSH-Px), glutathione-S-transferase and glucose-6-phosphate 
dehydrogenase (Birben, Sahiner, Sackesen, Erzurum, & Kalayci, 2012). The non-enzymatic 
antioxidants are molecules that interact with nitrogen species (RNS), and terminate the free 
radical chain reactions (Liguori et al., 2018). The non-enzymatic antioxidants are bilirubin, 
α-tocopherol (vitamin E), β-carotene, albumin and uric acid (antioxidant capacity in plasma) 
(Wu, Kosten, & Zhang, 2013). Exogenous antioxidants consist of low molecular weight 
antioxidants like ascorbic acid (vitamin C), α-tocopherol, phenolic antioxidants, oil lecithins, 
selenium, zinc, and drugs such as acetylcysteine (Pisoschi & Pop, 2015).   
Plants have an efficient complex enzymatic and non-enzymatic antioxidant 
defense systems to avoid the toxic effects of free radicals. Plants synthesize antioxidant 
enzymes (glutathione and ascorbate) within the chloroplast stroma and cytosol using 
nicotinamide adenine dinucleotide phosphate (NADPH) as the ultimate electron donor. In 
addition, they generate ascorbic acid during aerobic metabolism (Kasote et al., 2015). In 
chloroplasts and protoplastids, plants also synthetize vitamin E.  Plant antioxidants such as 
ascorbic acid and flavonoids have been shown to be the best exogenous antioxidants 
(Foyer & Noctor, 2005). In addition, several studies have showed that polyphenols are the 
most common natural products to improve the function of stressed mitochondria (Brand et 
al., 2018).  
 
 
 
Dietary supplements with green tea marketed in Portugal: information on websites, labels and antioxidant activity 
 
20 
 
1.2.2. Antioxidant Activity and Green tea 
 
Fruits, vegetables, and some other natural products which are rich in antioxidants 
can reduce oxidative stress in vivo, and might be an effective approach for preventing 
diseases (Liu et al., 2018). Most of the observed therapeutic effects of plants have been 
linked to their potent antioxidant activity (Foyer & Noctor, 2005).  
 It is estimated that more than 4000 flavonoids have been identified in plants, and 
the list is constantly growing (Harborne & Williams, 2000). In addition, tea, coffee, red wine, 
cereals and chocolate contribute for daily total polyphenol intake (Scalbert, Johnson, & 
Saltmarsh, 2005). Consumption of tea intensifies the body’s antioxidant activity, and 
increase activity of basic antioxidant enzymes such as: glutathione reductase, GSH-Px, 
CAT, glutathione S-transferase and quinone reductase (Winiarska-Mieczan, 2018). The 
antioxidant properties of green tea result from their chemical composition (view 1.4.1.1.). It 
was demonstrated that the antioxidant potential in blood plasma after drinking green tea is 
increased by 34%, while after drinking black tea the increase is 29% (Serafini, Ghiselli, & 
Ferro-Luzzi, 1996). The same study also demonstrated that drinking 300 ml of green tea 
increases the antioxidant capacity of blood plasma by 40% in 30 minutes; however, even 
80 minutes after consumption, this value reaches the baseline (Serafini et al., 1996). 
Over the last years, several studies have been performed in order to investigate the 
antioxidant activity of green tea. Table I summarizes the studies carried out in the last ten 
years (from 2008 to 2018), regarding the evaluation of in vitro antioxidant activity of green 
tea.  
Some authors evaluated this antioxidant activity isolated or compared green tea to 
black tea and other plants (Anesini, Ferraro, & Filip, 2008; Jung, Song, & Choe, 2016; Kerio, 
Wachira, Wanyoko, & Rotich, 2013; Tsai, Tsai, Chien, Lee, & Tsai, 2008). Also, some studies 
were developed to understand the correlation between green tea antioxidant proprieties 
and prevention of several diseases or human conditions (Annunziata et al., 2018; Posadino 
et al., 2017; Qin, Guo, Li, Wang, & Kim, 2013; Rani, Arora, Kaur, & Manhas, 2018; Wang et al., 
2014; Zhong et al., 2011). Results presented in table I highlight the importance of green tea 
in human health and its capacity as an effective antioxidant.  
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Table  I - Studies regarding the evaluation of in vitro antioxidant activity of green tea, in the last 10 years. 
Reference Aim of the study Methods Results/Conclusion 
Anesini et al., 
2008 
Determine the total polyphenol content 
and in vitro antioxidant capacity of green 
and black tea cultivated and 
industrialized in Argentina. 
- Twelve samples of eight brands. 
- Assays: Ferric thiocyanate method 
and DPPH free-radical scavenging 
assay. 
- Green tea showed a higher polyphenol content than 
black tea. 
- Antioxidant activities were well correlated with the 
total polyphenol content.  
Tsai et al., 2008 
Evaluate the antimicrobial activity 
against bacteria, total antioxidant 
capacity and phenolic constituents of 
methanolic extracts from different herbs 
compared with those of green tea 
- Methanolic extracts. 
- Assays: DPPH radical scavenging 
activity, trolox equivalent antioxidant 
capacity, oxygen radical absorbance 
capacity. 
- Green tea exhibited the highest antioxidant capacity. 
- Green tea may be an effective potential source of 
natural antioxidants. 
Zhong et al., 2011 
Determine the effects of tea catechins 
incubation on cell proliferation, cell 
membrane integrity, antioxidant 
enzyme activities, and antioxidant 
enzyme mRNA and protein expression 
in H2O2 stress -induced skeletal muscle 
cells (SMCs) of goats. 
- Tea catechins were isolated from 
green tea leaves. 
- Assays: CAT activity, CuZn-
superoxide dismutase activity, and 
GPx activity  
- CAT and CuZn-SOD mRNA expression levels were 
increased by different concentrations of tea catechins 
incubation.  
- Tea catechins affected antioxidant status in SMCs by 
modulating antioxidant enzyme activities at mRNA and 
protein expression levels. 
Kerio et al., 2013 
Tea products from different cultivars 
were analyzed for total polyphenols, 
catechin profiles and in vitro antioxidant 
activities. 
- Polyphenols and catechins extracts 
were prepared from tea leaves.  
- Assays:  DPPH radical scavenging 
activity.  
- Antioxidant potency of teas is dependent on the 
predominant flavonoid compound, the type of tea 
cultivar and the processing method. 
- Cyanidin-3-O-glucoside was the anthocyanin most 
highly correlated with antioxidant activity.  
 
 
 
Dietary supplements with green tea marketed in Portugal: information on websites, labels and antioxidant activity 
 
22 
 
Table I - Studies regarding the evaluation of in vitro antioxidant activity of green tea, in the last 10 years (Continuation). 
References Aim of the study Methods Results/Conclusion 
Quin et al., 
2013 
Evaluate the in vitro wound healing potential of 
chitosan green tea polyphenols complex based 
on the activation of transglutaminase (TGM) 
genes in epidermal morphogenesis 
- Methanolic extraction (leaves) with 
different concentrations (30%, 40%, 
50%, 60%, 70%), time (2 to 6 h), and 
temperature (20°C to 80°C). 
- Assays: reducing power; DPPH 
method; chelating ability.  
- Green tea polyphenols showed antioxidant 
properties.  
- The efficacy of chitosan green tea polyphenols in 
wound healing based on these results may be 
ascribed to its antioxidant properties and activation 
of the expression of TGMs.  
Wang et al., 
2014 
The conditions for extracting polysaccharides 
from tea (Camellia sinensis L.) fruit peel were 
studied (temperature, time, and liquid/solid ratio) 
- Polysaccharides from fruit peel of 
tea. 
- Assays: FRAP, α-glucosidase 
inhibitory activity, 2,2'-azinobis (3-
ethylbenzothiazoline-6-sulfonic 
acid) diammonium salt (ABTS).  
- Remarkable scavenging activity on ABTS, reducing 
activity, and inhibitory potential against α-
glucosidase in vitro.  
- Tea fruit peel is a potentially valuable renewable 
bioresource for the development of polysaccharide 
antioxidants. 
Jung et al., 
2016 
Investigate the effects of the addition of gardenia 
seed, green tea, and cactus pear to rice batter on 
the chemical quality of lotus root bugak, including 
lipid oxidation, contents of antioxidants and 
pigments, and in vitro antioxidant activity 
- Assays: reducing power and DPPH 
radical scavenging activity. 
- In vitro antioxidant activity of lotus root bugak 
increased with the addition of gardenia seed, green 
tea, or cactus pear. 
- Green tea and gardenia seed could improve the 
health and food functionality of antioxidation for lotus 
root bugak, respectively.  
 
Posadino et 
al., 2017 
Investigate the impact of Polyphenol E on 
prostate cancer cells, analyze the potential 
signals involved and elucidate whether anti- or 
pro-oxidant effects may be implicated. 
 
- Polyphenon E (standardized green 
tea extract). 
At the tested concentrations, Polyphenol E did not 
exert any antioxidant activity, eliciting instead a pro-
oxidant effect at concentrations 30 and 100 μg/ml 
(consistent with the observed Polyphenol E 
cytotoxicity).  
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Table I - Studies regarding the evaluation of in vitro antioxidant activity of green tea, in the last 10 years (Continuation).  
 
References Aim of the study Methods Results/Conclusion 
Rani et al., 2018 
Evaluate phenolic compounds as antioxidants 
and chemopreventive drugs from 
Streptomyces cellulosae strain TES17 isolated 
from rhizosphere of Camellia sinensis 
- Strain TES17 isolated from soil 
sample collected from 
rhizosphere of tea plant 
- Assays: DPPH radical 
scavenging assay; ABTS radical 
scavenging activity; Superoxide 
anion scavenging assay; 
Phosphomolybdenum assay; 
Reducing power assay; Lipid 
peroxidation assay.  
- The extract of Streptomyces cellulosae strain 
TES17 demonstrated significant antioxidant activity 
with percentage inhibition of 78.47, 91.08 and 82.08 
for DPPH, ABTS and superoxide radical assays at 
5 mg/mL, respectively.  
- The antioxidant capacity of extract was well 
correlated with its total phenolic content and total 
flavonoid content.  
- S. cellulosae strain TES17 isolated from the 
rhizosphere of Camellia sinensis plant produces 
potent compounds with antioxidant activity, further 
might be developed into therapeutic drugs to combat 
oxidative stress. 
Annunziata et al., 
2018 
Evaluation of colon bio accessibility and 
antioxidant activity of tea polyphenolic extract. 
- 80% methanolic extract (v/v) of 
tea polyphenols was obtained 
from green, white and black tea. 
- Assays: DPPH and ABTS.  
- After in vitro GI digestion, tea polyphenol 
bioaccessibility and antioxidant activity are higher in 
the colon than in the duodenum.  
- Polyphenols are poorly absorbed in the duodenum. 
However, they can exert their antioxidant and anti-
inflammatory activities in the lower gut, resulting in a 
novel strategy for the management of gut-related 
inflammatory diseases. 
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Abstract  
 
Introduction: The use of plants and its health benefits have been recognized over the years. 
Nowadays, internet is one of the most required options to buy dietary supplements. 
However, several studies suggest that information on most sites is incomplete, poorly 
referenced, and may contain illegal claims. This study aims, therefore, to evaluate the 
information on Portuguese websites where supplements with green tea can be purchased.  
Methods: Cross-sectional survey of 30 websites, including pharmacies/parapharmacies, 
health food stores, and online shopping websites. They were identified through Google® in 
December 2017, and a modified version of DISCERN instrument was used to determine 
information quality. Rating scores were analyzed and quality was assessed according to the 
scores and websites content. 
Results/Discussion: Overall, all websites scored 1 (20%) or 2 (80%) and no site received a 
score of 3, 4 or 5. The online shopping websites had the best results. However, in 
pharmacies and parapharmacies the results were most consistent. It was also observed 
that in all websites, questions one and four showed the lowest score: “Is it clear what 
sources of information were used to compile the information on the e-commerce website 
(other than the author or producer?”; “Does the webpage provide details of additional 
sources of support and information?”. These results can be explained by the legislation 
related to dietary supplements. In Portugal, as well as in other European countries, many 
products containing medicinal plants are sold as dietary supplements and are not covered 
by applicable legislation for herbal medicines. Products with green tea have 
contraindications, adverse effects and precautions associated with its use. Nevertheless, 
the majority of websites scored in this study provided insufficient or poor-quality 
information about these topics.  
Conclusion: This study’s results strongly support the need for improved website information 
regarding its selling products. Also, consumer education about the benefits and risks of 
buying dietary supplements online is needed for, as informed and safe choice. 
 
Keywords: Green tea, Dietary Supplements, DISCERN, Information, Quality, Websites 
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Introduction  
 
Plants have been used for centuries for food and medicine, and in many developing 
countries, populations still rely on traditional medicine for primary health care (Prinsloo et 
al., 2018). The use of herbal remedies, has also been widely accepted in developed 
countries, including United Kingdom, France and Germany (Braun et al., 2010; Calapai, 
2008; Ekor, 2014). Phytotherapy has gained popularity in developed and developing 
countries because herbal medicines are seen as a safe, nonaggressive and holistic approach 
to healing (Kristanc & Kreft, 2016).   
Nowadays, Internet has become an essential health information searching tool and 
an easy method to buy dietary supplements (DS). Health consumers are increasingly using 
the Internet to access health information and purchase health products (Thakor et al., 2011). 
The advantages of the Internet as a source of health information include easy access to a 
massive volume of information and ease of updating information. Online health information 
can make consumers better informed, maximizing, therefore, health outcomes (Jallon, 
1997). However, several studies suggest that information on most sites is incomplete, 
poorly referenced, and may contain illegal claims (Walji et al., 2004), as it is not always 
written by health professionals. Moreover, most information search engines do not use any 
kind of filter to select trustworthy information (Batchelor & Ohya, 2009). One concern and 
public health issue is internet’s health information quality. Due to its deregulated nature, it is 
impossible to control the information that in uploaded online. So, health information on the 
web varies substantially in quality, accuracy, and readability (Moody et al., 2007). Therefore, 
the quality of information available online needs to be ensured, and attempts have been 
made to estimate the individual risk of finding an inadequate information regarding various 
health conditions (Maloney, Ilic, & Green, 2005).  
Camellia Sinensis (L.) O. Kuntze, known as green tea, is one of the most consumed 
plants in the world, and an important plant used as an antioxidant with abundant health 
benefits (Hodgson & Croft, 2010). It is also an example of a widely used herbal medicine 
marketed extensively online. Besides direct green tea consumption, various processed 
goods (including cosmetics, medicines, and food additives) containing green tea have been 
developed over the years. Green tea leaves contain antioxidative catechins, what justifies 
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its many health benefits such as antibacterial, anti-inflammatory, antidiabetic and weight 
loss activities (Zaveri, 2006). 
Given the rapid grown of green tea market (Park, 2008), its easy online purchase, and 
the adverse reactions, contraindications and interactions associated with its use, it is 
important that health websites contain high quality information in order to adequately 
inform consumers. What is also unclear is whether the type of website (e.g. pharmacy, 
parapharmacy, health food store) has any influence on the quality of information presented. 
Similar studies performed with other plants suggest that the information presented 
on websites is poor (Bessell, Anderson, Sansom, & Hiller, 2003; Thakor et al., 2011). Several 
solutions have been proposed to address the information quality and reliability issues found 
on websites. The DISCERN quality index tool is one way to evaluate the reliability and quality 
of online health information and treatment choices (Khazaal et al., 2009).  
For all the above mentioned, this study aims to evaluate the overall website quality 
selling green tea supplements.  
 
Methods  
 
Search strategy 
 
To select the different websites evaluated in the present work, a Google® search was 
performed on December 2017, in order to identify websites that sold green tea supplements 
in Portugal, using the following search terms: [Buy] AND [Green Tea OR Camellia sinensis] 
AND [Capsules OR Tablets] AND [Pharmacy OR Parapharmacy OR Food Health Store].  
 
Inclusion/exclusion criteria 
 
To stratify the results, the following inclusion criteria were applied: a) supplements 
containing green tea isolated or in combination with other plants and/or substances; b) 
green tea supplements in capsules or tablets; c) portuguese websites; d) three categories of 
websites, namely, online pharmacies/parapharmacies, online food health stores, and online 
websites without a physical space. As for exclusion criteria: websites that only refer green 
tea information or their biological activities; duplicate websites and supplements. Through 
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this method, the first ten websites, retrieved by Google®, of each category (thirty in total) 
were selected. 
 
 
Data collection procedures 
 
DISCERN instrument is a validated 16-item questionnaire on a continuous rating 
scale of 1 (definite NO) to 5 (definite YES), used to evaluate quality of written information on 
health-related websites. Any rating between 1-5 indicates that some of the elements 
assessed by the items are presented to a certain extent (Chanock et al., 1999).  
The 16 questions are categorized into three sections Section 1 (questions 1 to 8) 
assesses reliability, dependability and trustworthiness of a website (with a maximum score 
of 40 points) (Chanock et al., 1999). Treatment choices quality information is measured on 
Section 2 (questions 9 to 15) with a maximum score of 35 points; and Section 3 (question 
16), evaluates overall publication quality rating. So, the score that a website can reach would 
be between 0-80 points and each website was classified as ‘‘excellent’’ (68–80), ‘‘good’’ 
(55–67), ‘‘fair’’ (42–54), ‘‘poor’’ (29–41), or ‘‘very poor’’ (16–28) (Charnock et al., 1999).  
In this work a modified version of DISCERN was used to evaluate the quality of the 
30 websites selling dietary supplements containing green tea (Thakor, Leach, Gillham, & 
Esterman, 2011). Briefly, the modifications consisted of: (i) removing the first three 
questions of section one due to the lack of relevance to e-commerce websites, (ii) adding 
specific and objective descriptors for responses to questions 9 through 15 (section two), (iii) 
changing question 10 from treatment benefit to specific indications for green tea, (iv) 
dividing question 11 into three separate questions, related on adverse reactions, drug 
interactions and contraindications, and (v) adding a question on ease of access to 
information. The final section (question 16) assessed the overall quality rating of online e-
commerce websites (Thakor et al., 2011). 
The modified DISCERN instrument was tested for face validity by three researchers, 
on a small sample of six e-commerce websites, consisting of two sites from each category. 
Data were analyzed using Microsoft Excel® version 2016. 
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Results  
 
Of the 30 websites scored, modified DISCERN tool indicated that all websites fell 
below the maximum score (80 points). Applying the modified DISCERN tool, the score 
average for the questions regarding reliability was 27.1 (in a maximum of 80 possible 
points). The websites without a physical space scored 27.5, the websites from health food 
stores scored 27 and finally the websites from pharmacies/parapharmacies scored 26.9.  
Regarding overall quality, the maximum score achieved by one of the websites 
according to DISCERN tool was 37/80 (related to one online food health store), and the 
lowest one was 19/80 (related to one website without a physical space). The overall 
average score was 34.8/80 and classified as “poor”. Analyzing by categories, websites 
without a physical space have an average score of 40.3 points, pharmacies/ 
parapharmacies have an average score of 32.7 points and online health food stores have an 
average score of 31.3 points. Also, DISCERN instrument rated 9 (30.0%) websites as ‘‘very 
poor” (3 websites from pharmacies/parapharmacies, 5 websites from food health stores, 
and 1 website without physical space).  
 Based on the item 16 of the modified DISCERN tool (section 4 – Overall Rating of the 
Website) all websites scored 1 or 2 (Low – serious or extensive outcomes). Six websites 
scored 1 (20%) and 24 scored 2 (80%) (Figure I).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure I - Overall quality rating of websites selling dietary supplements (DISCERN instrument 
question 16) 
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Analyzing the results per category, 90% of the online pharmacies/parapharmacies, 
80% of the online food health stores, and 70% of the websites without a physical space 
score 2 (Table I). 
 
 
Table I - Overall quality rating of websites selling dietary supplements per category (DISCERN 
instrument question 16) 
Quality rating 
Category of Website 
Total Pharmacy/ 
Parapharmacy 
Health Food  
Store 
Websites without 
physical space 
N % N % N % N % 
1 1 10 3 30 2 20 6 20 
2 9 90 7 70 8 80 24 80 
3 0 0 0 0 0 0 0 0 
4 0 0 0 0 0 0 0 0 
5 0 0 0 0 0 0 0 0 
Total 10 100 10 100 10 100 30 100 
 
     
 For all the categories, question 15 (Is the information related to green tea most 
visible and easy to access?) had the best score, with an average of 3.9; 4.0 and 4.1 for 
websites without a physical space, online pharmacies/parapharmacies, and online health 
stores, respectively. The questions 6 (Does the webpage describe how green tea works?) 
and 7 (Does the webpage describe the indications of green tea?) also presented good 
scores, in comparison to the rest. The questions with lower average (score 1) were 1, 4, 11, 12 
and 13 for online health stores; questions 1, 4, 8, 10 and 13 for online 
pharmacies/parapharmacies; and questions 1, 4, 8, 10 and 11 (Figure II). 
 The questions 1 [Is it clear what sources of information were used to compile the 
information on the e-commerce website (other than the author or producer)?] and 4 (Does 
the webpage provide details of additional sources of support and information?) were 
common, regarding the lowest score, in all websites categories (Figure II).   
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Figure II- Quality ratings for the 30 websites per DISCERN instrument question (average). 
 
 
Discussion  
 
Online health information can harm as well as heal and many quality criteria have 
been suggested to help consumers identify misleading, inaccurate, or harmful information 
(Walji et al., 2004). As more people are searching the web for health-related information, 
there is a need to provide credible and useful data.  
Although there are more than 90 described tools for evaluating online health 
information, in this study the modified DISCERN tool was chosen because it represents a 
structured approach to assess information quality published online, on websites selling DS 
(Thakor et al., 2011).  
This study has shown that the information quality on most websites is generally 
poor. The fact that this study identified almost all websites scoring ‘‘poor’’ is a negative 
aspect of the present quality of online health information. This finding is consistent with 
other studies (Martin-Facklam, Kostrzewa, Schubert, Gasse, & Haefeli, 2002; Walji et al., 
2004). For example, in their study, Martin-Faclam et al., (2002) revealed that content 
quality for websites about St. John’s wort, as reflected by stating clinically relevant drug-
drug interactions and the correct indication for its use, is low. Also, Walji et al., (2004) 
analyzed 150 websites retrieved from a search for the three most popular herbs: ginseng, 
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ginkgo and St. John's wort and their purported uses. They concluded that 38 websites (25%) 
contained statements that could lead to direct physical harm if acted upon, and 145 
websites (97%) omitted information. Finally, Thakor et al., 2011 showed that the majority of 
websites analyzed in their study were poorly rated with a concerning lack of information 
about the interaction between Hypericum perforatum and some drugs. Most sites also 
failed to provide sufficient information about contraindications and adverse effects of 
hypericum treatment. 
The results observed in this study can be explained by the legislation related to DS. 
In Portugal, as well as in other European countries, many products containing medicinal 
plants are sold as DS and are not covered by applicable legislation for herbal medicines 
(Decreto-Lei n. º 136/2003). In addition, labeling, safety, and efficacy information is not 
required to be posted on websites selling DS, although its presence would be beneficial for 
the consumer to make informed purchasing decisions (Jordan & Haywood, 2007). 
Thus, manufacturers may claim “indications” for their products without support 
from appropriate studies (Martin-Facklam et al., 2002). 
Also, in many DS information was presented in a sensational, emotive or alarmist 
way, for example: “This product offers a possibility of a slender body, even for the lazy ones”; 
“powerful antioxidant”; “the purest green tea extract on the market”.  
DS with green tea have indications of use, however there are also adverse reactions, 
contraindications and interactions associated with its use. Nevertheless, the majority of 
websites analyzed provided insufficient or poor-quality information about these topics. 
Almost all websites omitted drug interactions and adverse reactions. This is concerning 
because many consumers perceive "natural" products as safe. Further, many plants that 
may be safe when used alone interact with conventional medications (Walji et al., 2004). 
Green tea’s EGCG, ECG, EGC, EC are responsible for these interactions (Werba et al., 2018). 
Many studies related interactions with cardiovascular drugs (Werba et al., 2018), potentially 
leading to reduced drug efficacy or increased risk of drug toxicity (Catapano et al., 2017). 
However, the risk of interactions might be higher in patients who consume high volumes of 
green tea and infusions with high catechin content (Werba et al., 2018). Because 
pharmacokinetic interactions were mentioned in only one website (from an online health 
store), patients might combine green tea with other drug therapy, unaware of adverse drug 
interactions that might reduce the efficacy of their treatment. 
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Also, none website referred sources of information used to compile the information 
on e-commerce website (other than the author or producer). Citation of scientific sources 
may serve as indicators of reliable drug information (Allam, Schulz, & Krauthammer, 2017). 
This study also showed best overall results for websites without a physical space. 
This can be explained because in pharmacies, parapharmacies and health food stores, 
consumers can always resort to the professional for counselling (Kwan et al., 2008). 
However, because this counseling cannot happen in websites without a physical space, 
they need to have more information available.  
 
Conclusion  
 
Both consumers and professionals should be made aware that websites providing 
information currently have widespread variability in quality. The development of a checklist 
for the online marketing of herbal products, based on DISCERN instrument, or other similar 
instrument, may help prevent important concerns from being overlooked, such as drug 
interactions and contraindications. These instruments can guide health professionals, who 
have a role in directing patients to high-quality sources of information. It is important to 
notice that online information is essential for an adequate purchase. Also, consumer 
education about the benefits and risks of buying dietary supplements online is needed for, 
as an informed and safe choice. The results of this study strongly support the need for 
improved online information regarding its selling products. 
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Annex I  
 
 
MODIFIED DISCERN TOOL 
 
 
SECTION 1: Is the publication reliable? 
 
1. Is it clear what sources of information were used to compile the information on the e-
commerce website (other than the author or produced)? 
Rating this question: 
No  Partially  Yes 
1 2 3 4 5 
 
HINT: 
• Check whether the main claims or statements made about treatment choices are 
accompanied by a reference to the sources used as evidence, e.g. research study or expert 
opinion. 
• Look for a means of checking the sources used such as a bibliography/reference list or the 
addresses of the experts or organizations quoted, or external links to the online sources. 
 
Rating note: In order to score a full '5' the publication should fulfill both hints. Lists of additional 
sources of support and information (Question 7) are not necessarily sources of evidence for the 
current publication. 
 
 
2. Is it clear when the information used or detailed on the e-commerce website was 
produced? 
 
Rating this question: 
No  Partially  Yes 
1 2 3 4 5 
 
HINT look for: 
• dates of the main sources of information used to compile the publication 
• date of any revisions of the publication (but not dates of reprinting in the case of print 
publications) 
• date of publication (copyright date). 
 
 
Rating note: The hints are placed in order of importance - in order to score a full '5' the dates relating 
to the first hint should be found. 
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3. Is the information balanced and unbiased? 
Rating this question: 
No  Partially  Yes 
1 2 3 4 5 
 
HINT look for: 
• a clear indication of whether the publication is written from a personal or objective point of 
view 
• evidence that a range of sources of information was used to compile the publication, e.g. 
more than one 
• research study or expert evidence of an external assessment of the publication. 
 
Be wary if: 
• the publication focuses on the advantages or disadvantages of one particular treatment 
choice without reference to other possible choices 
• the publication relies primarily on evidence from single cases (which may not be typical of 
people with this condition or of responses to a particular treatment) 
• the information is presented in a sensational, emotive or alarmist way. 
 
4. Does the webpage provide details of additional sources of support and information? 
 
Rating this question: 
No  Partially  Yes 
1 2 3 4 5 
 
HINT look for: 
• suggestions for further reading or for details of other organizations providing advice and 
information about the condition and treatment choices. 
 
5. Does the webpage refer to areas of uncertainty? 
 
Rating this question: 
No  Partially  Yes 
1 2 3 4 5 
 
HINT: 
• Look for discussion of the gaps in knowledge or differences in expert opinion 
concerning treatment choices. 
 
Be wary if:  
 
• the publication implies that a treatment choice affects everyone in the same way, e.g. 
100% success rate with a particular treatment. 
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SECTION 2: How good is the quality of information on treatment choices? 
 
These questions apply to the treatment (or treatments) described in the publication. Self-
care is considered a form of treatment throughout this section. 
 
 
6. Does the webpage describe how Green Tea plant works? 
 
Rating this question: 
No  Partially  Yes 
1 2 3 4 5 
 
HINT: 
• Look for a description of how Green tea acts on the body to achieve its effect. 
 
 
7. Does the webpage describe the indications of Green Tea? 
 
Rating this question: 
No  Partially  Yes 
1 2 3 4 5 
 
HINT: 
• Benefits can include controlling or getting rid of symptoms, preventing recurrence of the 
condition and eliminating the condition, both short-term and long-term. 
 
Judging criteria: 
1) No 
2) Yes, indications not recommended by German Commission E monograph or EMA 
3) Yes, a mixture of indications not recommended and recommended by German Commission E 
monograph and EMA 
4) Yes, only one indication recommended by German Commission E monograph or EMA 
5) Yes, more than one indication recommended by German Commission E monograph or EMA 
 
 
8. Are drug interactions mentioned? 
 
Rating this question: 
No  Partially  Yes 
1 2 3 4 5 
 
Judging criteria: 
1) Not mentioned OR wrong drugs mentioned OR includes the statement “no interactions present” 
2) At least one correct drug class is mentioned 
3) Yes, 2-4 correct drugs are explicitly mentioned 
4) Yes, more than 5 drugs are mentioned 
5) More than five drug interactions are mentioned AND the consumer is advised to consult a health 
professional if they have any of the contraindications 
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8.1. List of drugs interactions mentioned (circle all that apply):  
 
Iron  
Bronchodilators: E.g. Theophylline 
Coronary Vasodilators  
Tamoxifen  
Warfarin   
Stimulants (Central Nervous System)  
 
 
9. Are contra-indications of Green Tea treatment mentioned? 
 
Rating this question: 
No  Partially  Yes 
1 2 3 4 5 
 
Judging criteria: 
1) Not mentioned OR wrong contra-indications mentioned OR includes the statement “no 
contraindications present” 
2) At least one correct contraindication is mentioned 
3) Yes, 2-4 correct contraindications are explicitly mentioned 
4) 5-7 contraindications are mentioned 
5) More than seven contraindications are mentioned AND the consumer is advised to consult a 
health professional if they have any of the contraindications 
 
 
9.1. List of contraindications mentioned (circle all that apply): 
 
Known hypersensitive to green tea 
Breastfeeding  
Pregnancy 
Hyperthyroidism  
Gastric and duodenal ulcers  
Cardiovascular problems (hypertension, arrhythmia) 
Gastritis  
Psychological disorders (anxiety) 
Irritable bowel syndrome  
 
 
10. Are potential adverse effects of Green Tea treatment mentioned? 
 
Rating this question: 
No  Partially  Yes 
1 2 3 4 5 
 
Judging criteria: 
1) Not mentioned OR wrong adverse effects mentioned OR includes the statement “no adverse 
effect present” 
2) At least one correct adverse effect is mentioned 
3) Yes, 2-4 correct adverse effects are explicitly mentioned 
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4) 5-7 adverse effects are mentioned 
5) More than seven adverse effects are mentioned AND consumer is advised to consult a health 
professional if they experience an adverse effect with Green Tea 
 
10.1. List of adverse effect mentioned (circle all that apply): 
 
Irritability  
Insomnia  
Nervousness  
Tachycardia  
Anxiety  
Gastrointestinal mucosa irritability 
Hypertension  
Headache  
Tremor  
 
 
11. Does the website describe what would happen if no treatment is used? 
 
Rating this question: 
No  Partially  Yes 
1 2 3 4 5 
 
HINT: Look for 
• a description of the risks and benefits of postponing treatment, of watchful waiting (i.e. 
monitoring how the condition progresses without treatment) or of permanently forgoing 
treatment. 
 
 
12. Does the website describe how the treatment choices affect overall quality of life? 
 
Rating this question: 
No  Partially  Yes 
1 2 3 4 5 
 
HINT: Look for 
• description of the effects of the treatment choices on day-to-day activity 
• description of the effects of the treatment choices on relationships with family, friends 
and careers. 
 
13. Is it clear from the website that there may be more than one possible treatment choice? 
 
Rating this question: 
No  Partially  Yes 
1 2 3 4 5 
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HINT: Look for 
• a description of who is most likely to benefit from each treatment choice mentioned, and 
under what circumstances 
• suggestions of alternatives to consider or investigate further (including choices not fully 
described in the publication) before deciding whether to select or reject a particular 
treatment choice. 
 
14. Does the website provide support for shared decision-making? 
 
Rating this question: 
No  Partially  Yes 
1 2 3 4 5 
 
HINT: 
• Look for suggestions of things to discuss with family, friends, doctors or other health 
professionals concerning treatment choices. 
 
 
SECTION 3: Ease of access to information 
 
15.  Is the information related to Green Tea most visible and easy to access? 
 
Rating this question: 
No  Partially  Yes 
1 2 3 4 5 
 
Judging criteria: 
1) No information is cited on first click of the URL 
2) Only the name of the product is cited on first click of the URL; a link to another website is provided 
3) Only the name of the product is cited on first click of the URL; a link to another page is provided 
4) The product name, price and indications are cited on first click 
5) Information relating to indications, drug interactions, contraindications and adverse effects, is 
cited on first click 
 
 
SECTION 4: Overall Rating of the Website 
 
16. Based on the answers to all of the above questions, rate the overall quality of the 
website as a source of information about treatment choices 
 
Rating this question: 
 
No (Serious or 
extensive 
shortcomings) 
 Partially (Potentially 
important but not serious 
shortcomings) 
 Yes 
(Minimal 
shortcomings) 
1 2 3 4 5 
 
The original version of the DISCERN instrument is freely available from www.discern.org.uk 
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Abstract 
 
Introduction: Consumption of dietary supplements (DS) has increased in the last years in 
United States (US) and Europe. The legal framework for supplements varies among 
countries, and in Portugal, DS are regulated by Direção Geral de Alimentação e Veterinária 
(DGAV) according to Decree-Law No. 136/2003, 28 June. For that reason, clinical trials are 
not required for DS in Portugal, facilitating adulteration, falsification, contamination and 
incorrect labels. Therefore, DS safety is an important issue nowadays. For that reason, this 
study aims to evaluate overall information quality present in labels/leaflets of DS with 
green tea, marketed in Portugal. 
Methods: A cross-sectional survey was performed from December 2017 to February 2018. 
Information present in labels/leaflets of green tea DS marketed in Portugal were collected 
from stores. Products were evaluated according to the information required by law as well 
as overall composition, indications of use, plant part used, posology, adverse effects, 
supplement-drug interactions, and contraindications. Descriptive statistics were analysed 
using Microsoft Excel®. 
Results/Discussion: A total of twenty DS were analyzed. In case of DS with multiple active 
ingredients most common substances, besides green tea, were conjugated linoleic acid 
(CLA), chromium, L-carnitine and vitamin E. Regarding the evaluation criteria according to 
legal view, one supplement presented maximum score (7 points) and ten DS had the lowest 
score (6 points). In case of evaluation criteria according to scientific view, only one 
supplement presented 8 points (in a maximum of 9). Seven DS (35.0%) had indications of 
use similar to those mentioned in the literature. Adverse reactions and drug interactions 
information were rarely provided by two and three DS, respectively. 
Conclusion: Portugal compared to other countries in Europe or US has a weak and 
incomplete legal framework for DS. Manufactures still do not include much information in 
labels, because DS are still considered as “natural” and safe. New Regulation procedures 
should be created and a higher control of existing ones should be established in Portugal. 
Consumers can make informed health care choices, only when fully informed about the 
safety, efficacy and quality of products consumed for health promotion and disease 
prevention. 
Keywords: Camellia sinensis, Dietary Supplements, Green tea, Information, Labels, Quality 
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Introduction  
 
DS are defined as concentrated sources of nutrients or other substances with a 
nutritional or physiological effect that increases the overall dietary intake by supplementing 
the normal diet. They are marketed in measured doses (e.g., as pills, tablets, capsules, 
liquids) (Decreto-Lei n. º 136/2003). DS consumption has increased in the last years in US 
and Europe (Assena, 2010; Bailey et al., 2011; De Smet, 2005) as a strategy for disease 
prevention, for the correction of inadequate lifestyle habits, and for the improvement of 
physical performance (Bailey et al., 2011; Bailey et al., 2013; Dickinson & MacKay, 2014). In 
Portugal, DS consumption follows this world tendency (Fernandes, 2012). In 2017, one 
million and 983 thousand individuals (representing 23.2% of the portuguese residents with 
15 years or more) reported the intake of vitamins and/or other supplements over the 
previous 12 months (Grupo Marktest, 2017). 
Supplements legal framework varies among countries, even when they have similar 
cultures, legal systems, and levels of economic development (Chow et al., 2005). In the 
European Union (EU) some steps were taken, in order to harmonize the regulation of 
nutritional supplements, health foods, and herbal medicines. For that reason, European 
Commission has published directives regulating food supplements (2002/46/EC) and 
herbal remedies (2004/24/EC and 2004/27/EC) (European Parliament, 2002, 2004). In 
Portugal, DS are regulated by the Direção Geral de Alimentação e Veterinária (DGAV). 
However, the responsibility for supplement’s safety is placed on the manufacturer or 
marketer of the substance, and not on DGAV. 
According to Decree-Law No. 136/2003, 28 June and Decree-Law No. 118/2015, 
23 June the DS labelling must contain the following requirements: (i) names of nutrients or 
substances categories, that characterize the product or an indication of those nutrients or 
substances nature; (ii) reference daily intake; (iii) warning for daily intake should not be 
exceeded; (iv) a declaration to the effect that the supplement is not a substitute for a varied 
diet; (v) warning to keep out of reach of children. In addition, the DS labelling must not 
contain: (i) any statement attributing to the product properties of preventing, treating, or 
curing a human disease; and (ii) any mention stating or implying that a balanced and varied 
diet cannot provide appropriate quantities of nutrients in general (Decreto-Lei n. º 
136/2003).  
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The requirements for placing on the market DS do not comprise a safety 
assessment, and in accordance with Regulation (EC) No.178/2002, a food is by nature safe. 
For that reason, clinical trials are not required for DS in Portugal, facilitating, therefore, 
adulteration, falsification, contamination and incorrect labels. Other problems related to DS 
consumption include adverse reactions, contraindications and drug-supplements 
interactions. Therefore, DS safety is an important issue nowadays (DGAV, 2018).  
In Portugal, DS can be sold in pharmacies, parapharmacies, supermarkets, dietetic 
stores and over the internet, and consumers should be able to make informed and 
appropriate health care choices. Also, consumers use DS labels (information provided on the 
packaging) and leaflets to increase their understanding about some DS ingredients, relevant 
indication(s), directions for use, side effects, contraindications and drug-supplements 
interactions. Consequently, DS labels and leaflets must deliver useful, accurate information 
and in an understandable manner (Nabors, Lehmkuhl, Parkins, & Drury, 2004).  
For all the above mentioned, the present study aimed to evaluate the overall 
information quality present in labels and leaflets of DS with green tea, marketed in Portugal. 
 
Methods 
 
Search strategy 
  
In order to select the green tea supplements to be used, a Google® search was first 
performed on December 2017, in order to identify online pharmacies/parapharmacies and 
online food health stores that marketed these products in Portugal. The following search 
items were used: [Buy] AND [Green Tea OR Camellia sinensis] AND [Capsules OR Tablets] 
AND [Pharmacy OR Parapharmacy OR Food Health Store]. First DS appearing on websites 
were selected and information present in labels and leaflets was collected in stores. For 
data collection an adapted form was used (Jordan & Haywood, 2007) with eighteen 
questions divided in two parts: (1) Information related to DS legislation; and (2) Information 
related to scientific topics of the plant. Additionally, information regarding plant´s scientific 
name; plant part used; presence of standardized extract, presence of leaflet, and presence 
of vitamins and minerals was also recorded (Annex I).  
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Inclusion/exclusion criteria 
 
For DS selection, the following inclusion criteria were applied: a) supplements 
containing green tea isolated or in combination with other plants and/or substances; b) 
green tea supplements in capsules or tablets; c) portuguese websites; d) two categories of 
websites, namely, online pharmacies/parapharmacies and online food health stores. As for 
exclusion criteria: websites that only refer green tea information or their biological activities; 
duplicate websites and DS. Through this method, the first ten DS, retrieved by Google®, of 
each category (twenty in total) were selected. 
 
Evaluation criteria and quality score 
 
Each DS was evaluated according to the required information by portuguese law 
(legal view) and to relevant information for both professional and general public (scientific 
view). Each item analysed was marked as being ‘present’ (1 point), ‘absent’ (0 points) or 
‘incomplete’ (0.5 points). 
From a legal view, a point has been assigned when information was in agreement 
with Decree-Law No. 136/2003, of 28 June and Decree-Law No. 118/2015, of 23 June 
(maximum of 7 points). From a scientific view information related to composition, indication 
of use, adverse effects, interactions, contraindications, posology, common and scientific 
name, and plant part used were analysed based on literature (maximum of 9 points). 
Descriptive statistics were analyzed using Microsoft Excel®. 
 
Results  
 
Green tea DS selected from pharmacies/parapharmacies and health food stores 
websites were analyzed, after collecting its labels and leaflets in stores. Regarding the 
results, products were delivered as tablets (5; 25.0%) and capsules (15; 75.0%); the majority 
were multi-ingredient (17; 85.0%) versus single (3; 15.0%). Composition of the twenty DS 
analyzed are presented in Table I. In case of DS with multiple ingredients most common 
substances were CLA, chromium, L-carnitine and vitamin E (Table I).  
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Table I - Composition of DS analyzed.  
Number of DS Ingredients of DS 
1 Camellia sinensis, CLA 
2 Camellia sinensis, CLA, L-Carnitine 
3 Camellia sinensis, Chitosan, Vitamin C 
4 Camellia sinensis, Taraxacum officinale, Vitis vinífera 
5 
Camellia sinensis, Fructus rubis, Coffea arabica, Garcinia cambogia, 
Euterpe oleacea, Citrus grandis, Fucus vesiculosus, Chromium 
6 Camellia sinensis 
7 
Camellia sinensis, Centella asiatica,  Taraxacum officinale, Phaseolus 
vulgaris 
8 Camellia Sinensis, CLA 
9 
Camellia sinensis, Chitosan, Garcinia Cambodia, Peumus Boldus, 
Rhamnus sagrada, Passiflora incarnata 
10 Camellia sinensis, CLA, Ilex paraguariensis, Vitamin E 
11 Camellia sinensis 
12 Camellia sinensis, CLA, Ilex paraguariensis, Vitamin E 
13 Camellia sinensis, β-carotene, Vitamin C 
14 
Camellia sinensis ,Rhodiola rosea, Coleus forskohlii, Centella asiatica, 
Equisetum arvense, Ruscus aculeatus, Capsicum frutescens, 
Chromium 
15 
Camellia sinensis, Rhodiola Rosae L., Coleus forskohlii, Caffeine, 
Acetil-L-Tyrosine, Tyrosine, Phenylalaine, β-Sitosterol, Chromium, 
Selenium, Iodine 
16 Camellia sinensis 
17 Camellia sinensis, CLA, Vitamin E 
18 Camellia sinensis, CLA 
19 Camellia sinensis, CLA, L-Carnitine 
20 
Camellia sinensis, L-Carnitine, Paullinia cupana, Citrus aurantium, 
Theobroma cacau, Chromium 
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Evaluation criteria according to legal view 
 
 Table II shows, for a legal view, the number of DS that referred each of the seven 
possible topics. All DS have one point in topic 1 (statement of dietary supplement), 2 
(nutrients or substances categories), 4 (reference to daily intake of the DS can´t be 
exceeded), 5 (DS must not be used as a substitute for varied food regime), 6 (DS should be 
kept out of the children’s reach) and 7 (absence mention that attributes prophylactic, 
treatment or curative properties in human diseases) (Table II).  
In topic 3 (reference daily intake for DS) 0.5 point were attributed for an incomplete 
answer. For this topic, only DS number 3 obtained a score of one. DS number 4, 10, 12, 14, 15, 
17 and 18 have recommended daily dose for other substances present in the products, 
namely vitamin E, chromium, selenium and iodine (Table II).  
Finally, for this part of the form, DS number 3 has the best score (7 points) and 12 
supplements had the lowest score (6 points) (Table II). 
 
Evaluation criteria according to scientific view 
 
Table III shows, as for scientific aspects, the number of DS that referred each of the 
nine possible topics. All DS indicated the green tea’s common name, information on active 
substances and its exact quantity (quantitative composition) and posology (in labels and/or 
leaflets) (Table III). In case of posology for DS with only green tea as an active ingredient 
(three DS), all referred the recommended daily intake dose extract.  
Regarding green tea’s scientific name, 90.0% of DS indicated scientific name 
(Camellia sinensis). However, in two DS it wasn´t correctly written. Analyzing the plant part 
used in green tea, 50.0% of DS indicated this information in the product (leaves). Seven 
(35.0%) mentioned indications of use similar to those mentioned in the literature. Warnings 
about potential adverse effects, contraindications/precautions of use and interactions 
appears in two (10.0%), sixteen (80.0%) and three (15.0%) DS, respectively. DS number 20 
had the highest score (8 points) and numbers 1 and 3 had the lowest score (4 points) (Table 
III).  
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Table II - Topics for evaluation criteria according to legal view for the twenty DS 
 
Topics for evaluation criteria according to legal 
view 
 
Dietary Supplements Total  
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 N % 
1. A statement that product is a dietary supplement 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 20 100 
2. Description of the nutrients or substances 
categories which characterize the supplement  
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 20 100 
3. Reference daily intake of the DS  0 0 1 0.5 0 0 0 0 0 0.5 0 0.5 0 0.5 0.5 0 0.5 0 0 0.5 4.5 22.5 
4. A disclaimer that the reference daily intake of 
the DS can´t be exceeded.  
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 20 100 
5. A disclaimer that DS must not be used as a 
substitute for a varied food regime.  
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 20 100 
6. A disclaimer that DS should be kept out of the 
reach of children.  
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 20 100 
7. Absence mention that attributes prophylactic, 
treatment or curative properties in human 
diseases 
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 20 100 
TOTAL (7 possible points)  6 6 7 6.5 6 6 6 6 6 6.5 6 6.5 6 6.5 6.5 6 6.5 6 6 6.5   
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Topics for evaluation criteria according to scientific 
view 
Dietary Supplements    Total  
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 N % 
1. Common name 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 20 100 
2. Scientific name 0 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 18 90 
3. Information on active substances and their exact 
quantity (quantitative composition) 
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 20 100 
4. Plant part  0 0 0 1 0 1 1 0 1 0 1 0 1 1 1 1 0 0 0 1 10 50.0 
5. Posology 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 20 100 
6. Indication of use 1 1 0 1 0 0 0 1 0 0 1 0 0 0 1 0 0 0 0 1 7 35 
7. Adverse effects 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 2 10 
8. Contraindications/ Precautions of use 0 0 0 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 16 80 
9. Interactions 0 0 0 0 0 0 1 0 0 1 0 1 0 0 0 0 0 0 0 0 3 15 
TOTAL (9 possible points)  4 5 4 6 5 6 7 6 6 6 7 6 6 6 7 6 5 5 5 8   
Table III - Topics for evaluation criteria according to scientific view for the twenty DS 
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Table IV describes adverse effects, contraindications/precautions of use and 
interactions of green tea in DS with single-ingredient versus DS with multi-ingredients. 
Analyzing the results, only DS with more than one active ingredient referred adverse 
effects, with the most common being gastrointestinal disorders (DS number 8 and 20). 
Other adverse reactions listed included irritability and insomnia (DS number 8), and 
electrolyte imbalances (DS number 20). 
Regarding contraindications/precautions of use, sixteen DS related some of this 
information in the products. The most common was hypersensitivity or allergy to any of the 
components (mentioned in sixteen DS). DS number 18 also refers hypersensitivity or allergy 
to milk or fruits of the Rosaceae family. In case of DS with one single active ingredient (green 
tea) only one DS (DS number 11) didn´t recommend their use in pregnancy or breastfeeding; 
for DS with multi-ingredients, twelve products mentioned these contraindications. Other 
contraindications/precautions of use included contraindication to children below 12 years 
old, patients with cardiac diseases (hypertension), hyperthyroidism, patients with colon 
inflammatory diseases and abdominal pain, prolonged use, or intake with meals in order to 
minimize adverse effects (Table IV).  
Regarding interactions with drug, DS number 10, 12 and 17 referred substances that 
interact with green tea metabolization. All these three DS mentioned oral anticoagulants 
and/or antiplatelet agents as harmful substances (Table IV). 
Regarding DS´s uses, seven (35%) products indicated the situations where DS 
containing green tea can be used. The most common uses related to DS containing green 
tea were weight control. Some claims present in products included “burn fat”, “adipose 
tissue metabolism”, “thermogenic”, “appetite control” and “cellulitis”.  
In this study, DS information regarding the presence of a leaflet and 
vitamins/minerals was collected. Only five (25.0%) DS had leaflet. Some DS (9; 45.0%) 
presented vitamins and minerals in its composition, being chromium and vitamin E the most 
popular (present in four and three DS, respectively). Selenium, iodine and vitamin C were 
also present in DS (Table I).   
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Table IV - Adverse effects, contraindications/precautions of use and interactions present in single- ingredient vs multi-ingredient twenty green tea DS. 
 DS (single-ingredient) DS (multi-ingredient) 
Adverse effects 
 (DS 8) Gastrointestinal disorders: diarrhea, flatulence, abdominal pain, nausea; Irritability and insomnia 
(DS 20) Electrolyte imbalances (mostly cardiac patients). Abdominal pain and cramps 
Contraindications/ 
Precautions of use 
(DS 6,11,16) Hypersensitivity or 
allergy to any of the 
components  
(DS 11) Not recommended for 
pregnant women, children and 
breasting women  
(DS 5, 7, 8, 9, 10, 12, 14, 15, 17, 18, 19, 20) Hypersensitivity or allergy to any of the components. Not 
recommended for pregnant and breasting women  
(DS 8, 20) Not recommended for patients with cardiac diseases (hypertension) and hyperthyroidism. Not 
recommended for children under 12 years old 
(DS 5) In case of thyroid disease alerted medical monitoring 
(DS 8) Recommended DS intake with meals to minimize adverse effects 
(DS 14) DS has chromium: diabetics patients have to monitoring their values 
(DS 15) Not recommended use in athletes undergoing doping. Daily intake at night 
(DS 18) Hypersensitivity or allergy to milk or fruits of the Rosaceae family (e.g. peach, strawberry, apricot, 
pear fruit)  
(DS 20) Not recommend in patients with colon inflammatory diseases (Crohn's disease) and abdominal pain. 
Not recommended prolonged use. 
Interactions  (DS 10, 12, 17) Oral anticoagulants and/or antiplatelet agents as harmful substances  
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Discussion 
 
DS are classified as food and their purpose is to supplement the normal diet. This 
definition requires legal provisions of the food law (Noble, 2017). Its consumption requires 
some control, because these products can have adverse effects and contraindications, 
possibly endangering consumer’s health. Several studies related poor quality control, 
safety, misbranding, and adulteration to supplementation in many countries (Pawar & 
Grundel, 2017). 
 This study provides an information overview of green tea DS marketed in Portugal, 
and focuses on the legal information required in DS labelling and also on scientific 
information important for the effectiveness, quality and safety profile of these products. In 
order to have access to this information, labels and leaflets present in supplements were 
collected from pharmacies, parapharmacies and food health stores.  
  Supplements legal framework has been regularly updated in many countries, 
however, US (FDA) and Canada (Natural Health Products Regulations) have the most 
controlled guidelines for safety, quality and efficacy at DS selling (Government of Canada, 
2018; U.S Food & Drug Administration, 2018). Europe has been following these guidelines 
and European Commission has published directives regulating food supplements 
(2002/46/EC) and herbal remedies (2004/24/EC and 2004/27/EC) (European 
Parliament, 2002, 2004). Despite laws and directives in other countries and Europe, DS in 
Portugal still have a poor quality and safety control.  
 According to the portuguese law, DS labelling need to have the following 
disclaimers: “dietary supplement”, “recommended daily dose of the DS can´t be exceeded”, 
“DS must not be used as a substitute for a varied food regime”, “DS should be kept out of the 
children’s reach”. In addition, DS have to mention “recommended daily dose” and the 
warning that “DS are not intended to diagnose, treat, cure, or prevent any disease”. DS also 
need to describe the categories of nutrients or substances that characterize the supplement 
which characterize the supplement. These disclaimers are required in Portugal for selling a 
DS, and this study showed that information on many DS can be incomplete, poorly 
referenced, and may contain illegal claims. For example, many DS doesn’t reference daily 
intake of the products. This topic is very important for consumers, because failure 
recommended daily dose (excessive intake) may cause overdose. 
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Almost all supplements (87.5%) included the scientific name in the label/leaflet and 
all the twenty DS analyzed mentioned plant´s common name. However, and based on the 
literature, 80.0% referred scientific name correctly - Camellia sinensis (L.) Kuntze 
(Committee on Herbal Medicinal Products, 2013; Thorne Research Inc. 2002; Wollschlaeger 
et al., 2003). None DS analyzed provided scientific evidence in support of the products 
presented. Scientific information is important to give credibility to these products, but may 
also serve to lull a consumer into a false sense of safety and effectiveness. Manufacturers 
and vendors of DS know when and how to use scientific terminology as marketing tools, but 
when combined with the omission of key safety information, this only increases the 
likelihood of consumer use and potential harm (Owens, Baergen, & Puckett, 2014). 
Plants used for production of herbal medicines are commonly presented as powder 
obtained from dry plant, dry extract or standardized dry extract (Feltrin & Chorilli, 2010). 
However, efficacy of dry plant or dry extract cannot be compared to standardized dry 
extract, simply because there is no standard for the concentration of those substances 
considered as crucial for the pharmacological action (Feltrin & Chorilli, 2010). It is important 
to use products with the same extract used in clinical studies (standardized), to ensure the 
same percentage of content, especially regarding those substances responsible for plant 
therapeutically effect (Feltrin & Chorilli, 2010). In this study, seven (35.0%) DS mentioned 
green tea extract in their label. However, only one supplement (number 13) referred the use 
of green tea standardized dry extract (Standardized Green Tea Extract (leaf) - polyphenols 
200 mg [50%]). Posology mentioned in DS with green tea as the only active ingredient 
(three DS) were comparable to the daily intake dose recommended in literature (daily intake 
dose extract for DS number 6, 11 and 16 was 1500, 1200 and 1500 mg, respectively). 
According to Gruenwald, (2004) a daily dose of 300 to 400 mg of polyphenols is typical. For 
adjuvant treatment of control weight diets and functional asthenia, recommended dose is 
1.170 to 1.950 mg of powdered herbal substance daily (corresponding to approximately 35 
to 80 mg of caffeine) (Committee on Herbal Medicinal Products, 2013)  
Only ten (50%) DS mentioned the leaves as the plant part used in green tea, which 
is in agreement with literature (Committee on Herbal Medicinal Products, 2013; Gruenwald, 
2004; Wollschlaeger et al.,2003).  
According to Portuguese law, DS are not intended to diagnose, treat, cure, or prevent 
any disease, so disease claims are prohibited in these products. However, indications of use 
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may be a request in products to promote their selling. Only 35% of DS indicate its purpose 
of use and many of them were not in agreement with German Commission E monograph 
(treatment of diarrhea and asthenia) or by European Medicines Agency (EMA) (relief of 
fatigue and sensation of weakness). In this study, all DS with indication of use referred 
overweight as its main objective. Other recommendations of use/effects like “diuretic 
effect”, “strengthens the immune system” “lowers cholesterol levels” were also referred. 
Many studies have shown that green tea has a positive effect on the metabolism of lipid by 
different mechanisms (Huang et al., 2014; Sae-tan et al., 2011; Suzuki-Sugihara et al., 2016). 
However, controversies regarding the effects of green tea for overweight or obesity still 
remain (Diepvens et al., 2006; Mielgo-Ayuso et al., 2014).  
Green tea is one of the most popular beverages worldwide, and many preventive or 
therapeutic effects on common diseases are being attributed to its consumption and 
strongly publicized. This may encourage patients to consume these products as “natural”. 
However, green tea products may interfere by various mechanisms with the absorption, 
oral bioavailability, or activity of different drugs, potentially leading to reduced drug efficacy 
or increased risk of drug toxicity (Werba et al., 2015). Therefore, it is necessary to gather 
information on the ingredients in DS to facilitate medication safety efforts (Pawar & 
Grundel, 2017). In this study, sixteen (80%) supplements mentioned contraindications/ 
precautions of use. However, adverse reactions and drug interaction information were 
rarely provided by two and three DS, respectively. This might happen because it is not 
mandatory for manufacturers to provide this kind of information on DS label.  
Regarding contraindications, hypersensitivity or allergy to any of the components 
and use in pregnancy or breastfeeding, these warnings were present in almost 
supplements.  This kind of information is important, because a relatively large number of 
women use DS during pregnancy and believe that they are safe (Baudischova, Straznicka, 
Pokladnikova, & Jahodar, 2018).  
In this study, the most cited drug interactions included the concomitant use of DS 
containing green tea with oral anticoagulants and/or antiplatelet agents. Most data in the 
literature embrace the view that green tea may antagonize the effect of warfarin (Cheng, 
2007; Izzo, 2012; Izzo, Di Carlo, Borrelli, & Ernst, 2005; Wittkowsky, 2008). However, there 
is also a general agreement in assigning to the green tea-warfarin interaction a low level of 
evidence (Izzo, 2012) and a low probability of occurrence (Holbrook et al., 2005). Another 
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supplement-drug interaction referred in the literature is related to the use of green tea with 
simvastatin. Green tea can increase the exposure to some cardiovascular drugs (Werba et 
al., 2018). These drug-interaction increase simvastatin levels (Werba et al., 2018). 
Consumers need to be aware that there is a wide interindividual variability of the green tea’s 
effect on drug kinetics and, in some subjects, it might be clinically relevant, especially in 
people who assume large volumes of green tea and/or catechin-enriched products (Werba 
et al., 2015).  
Green tea is generally considered a safe and non-toxic beverage. However, there is 
a lack of tolerance and safety data on supplements containing green tea. The average cup 
of green tea, however, contains from 10-50 mg of caffeine and overconsumption may 
cause irritability, insomnia, nervousness, and tachycardia (Cunha et al., 2012; Mason, 2001). 
Adverse effects mentioned in DS analyzed included gastrointestinal disorders (diarrhea, 
flatulence, abdominal pain, nausea), irritability and insomnia, electrolyte imbalances (mostly 
cardiac patients), and abdominal pain and cramps. 
Finally, some DS analyzed in this study have vitamins and minerals (chromium, 
vitamin E, selenium, iodine, and vitamin C). Annexes I and II of Regulation (EC) No. 
1170/2009, defines which vitamins, minerals and units are allowed in DS. The results of the 
present study showed that all vitamins and minerals are in agreement with literature.  DS 
number 5, 14, 15 and 20 reported having 40 µg of chromium. Vitamin E was reported as 
present in DS 10, 12 and 17 at 20 mg. DS 3 reported having 80 mg of vitamin C and DS 15 has 
selenium (200 µg) and iodine (150 µg). Doses and units for all DS are in agreement to 
Annexes I and II of Regulation (EC) No. 1170/2009 (Parlamento Europeu, 2009).   
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Conclusion 
 
Portugal compared to other countries in Europe or US has a weak and incomplete 
legal framework for DS. Only seven disclaimers are required by Portuguese law, and 
manufactures still do not include all of them in label and/or leaflet of DS. Scientific 
information is not required in DS marketed in Portugal. This information’s omission can 
promote several drug-DS interactions. These interactions can originate adverse effects in 
consumers, which could endanger them and consequently overload health care facilities 
them in danger and overload hospitals and health centers. Stimulating Innovation 
Management of Polypharmacy and Adherence in The Elderly (SIMPATHY) project 
estimates that 8.6 million hospital admissions in Europe every year are caused by adverse 
drug event (SIMPATHY Consortium, 2017). For these reasons, new rules should be created 
and a higher control of existing ones should be established in Portugal and Europe for safety 
of their population. This study suggests that existing DS labels may not be satisfactory and 
require improvements to better support safe and appropriate use.
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Annex I 
 
Data collection form of information in DS containing green tea [adapted from Jordan & 
Haywood (2007)] 
 
Pharmaceutical form   ____________________________________________________________ 
Type of Dietary Supplement (single- or multi-ingredient) ____________________________ 
 
Part I – Information about food supplements legislation 
  
  A statement that product is a dietary supplement 
Presence of supplements' nutritional categories or substances that characterize the 
product or a specific reference to its nature.  
A disclaimer that DS are not intended to diagnose, treat, cure, or prevent any disease.  
Reference daily intake of the DS  
A disclaimer that the recommended daily dose of the DS can´t be exceeded.  
A disclaimer that DS must not be used as a substitute for a varied food regime.  
A disclaimer that DS should be kept out of the reach of children  
 
 
Part II – Scientific plant monograph information 
 
Vulgar name 
Scientific name 
Information on active substances and their exact quantity (quantitative composition) 
Plant part  
Posology 
Indication of use 
Adverse effects 
Contraindications/precautions of use 
Interactions 
 
Part III – Supplementary questions  
 
Patient information leaflet 
Vitamins and minerals present (units) 
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Abstract   
 
Introduction: Green tea is recognized by its antioxidant potential. Nowadays, the marketing 
of DS claiming protection against free radicals has increased. However, most labels include 
no data about its antioxidant properties. So, this study aims to evaluate antioxidant activity 
of six green tea DS sold in pharmacies and health foods stores in Portugal. 
Methods: Six commercial DS containing green tea were evaluated for in vitro antioxidant 
capacity by different methodologies: antiradical activity against 2,2-diphenyl-1-
picrylhydrazyl (DPPH), superoxide and metal chelating activity. EDTA, ascorbic acid and 
quercetin were used as standards. 
Results/Discussion: Great variability in antioxidant activity was seen among all DS, as well 
as different patterns of antioxidant capacity depending on the method used. Scavenging 
activities of the Fe2+ chelating, DPPH and superoxide radical for all DS studied were 
observed in concentration-dependent patterns. For Fe2+ chelating activity assay, only 
sample B showed antioxidant results (IC50 = 2681.6 ± 92.0 µg/mL). Sample E showed the 
best IC50 value for DPPH assay (31.6 ± 2.3 µg/mL). In superoxide assay IC50 values range 
from 44.7 to 265.3 μg/mL. In this study DS with only green tea as active ingredient showed 
the best results, with an IC50 value of 31.6 ± 2.3 μg/mL. In all samples (except for sample C), 
and for superoxide radical scavenging activity, IC50 values were lower than the positive 
control, ascorbic acid (IC50 = 77.5 ± 10.9 μg/mL), a well-known antioxidant. The variety of 
results obtained may be related to the composition and concentration of samples studied 
and the antioxidant mechanisms underlying. 
Conclusion: In vitro antioxidant activity of commercial dietary antioxidant supplements 
varies considerably among products, which is expected given the different botanical origins, 
different preparation processes, formulations, and concentrations. DS containing green tea 
with other substances didn´t show better results than DS with only green tea extract. These 
results show the need to standardize DS in terms of its antioxidant capacity to match 
required doses to the oxidative status of consumers.  
 
Keywords: Antioxidant Activity, Camellia Sinensis, Dietary Supplements, DPPH, Green Tea, 
Metal Chelating Activity, Superoxide 
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Introduction 
 
Tea is made from leaves of Camellia sinensis and is one of the most consumed 
beverages worldwide (Cunha et al., 2012). Among all of the different teas, the most 
significant effects on human health have been observed with green tea (Chacko et al., 2010). 
This plant has preventive effects on many diseases, including cardiovascular (Hodgson & 
Croft, 2010), neurodegenerative (Andrade & Assuncao, 2012) and cancer (Yuan, 2013), and 
biological activities like antibacterial, anti-inflammatory, and antidiabetic have been 
associated to green tea (Zaveri, 2006). Green tea is also one of the most common natural 
ingredients included in over-the-counter weight loss products available in many countries, 
because its extracts contain caffeine and catechin polyphenols (Janssens et al., 2016).  
Green tea is a complex mixture of several constituents, which include phenolic 
compounds (Dostal et al., 2015) like catechins, flavonoids, and phenolic acids (chlorogenic 
acid, caffeic acid, gallic acid) (Cunha et al., 2012). This chemical composition is associated 
with antioxidant activity, by the ability to directly scavenge reactive oxygen species (ROS) 
(Xiang et al., 2016).  
ROS are products of normal cellular metabolism and represent the most important 
class of radical species generated in living organisms (Valko et al., 2007). The imbalance 
between ROS and antioxidants results in oxidative stress, responsible for cellular damage 
(Saeed et al., 2017). Oxidative stress is involved in several age-related conditions 
(cardiovascular diseases, chronic obstructive pulmonary disease, chronic kidney disease, 
neurodegenerative diseases, and cancer) (Valko et al., 2007).   
Over the last years, several studies have been performed in order to investigate the 
antioxidant activity of green tea using either in vitro or in vivo approaches (Anesini et al., 
2008; Frei & Higdon, 2003; Jung et al., 2016; Kerio et al., 2013). Tea polyphenols act as 
antioxidants in vitro by scavenging ROS and reactive nitrogen species (RNS) and chelating 
redox-active transition metal ions. They may also function indirectly as antioxidants 
through inhibition of the redox-sensitive transcription factors; inhibition of pro-oxidant 
enzymes; and induction of phase II and antioxidant enzymes (Frei & Higdon, 2003).  
In vitro antioxidant activity assessment methods are often used to screen and 
confer antioxidant potential to plants or their phytochemicals and sometimes to understand 
the possible mechanism of action of plant antioxidants (Foyer & Noctor, 2005). Green tea 
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antioxidant activity can be revealed by different antioxidant assays like 2,2-diphenyl-1-
picrylhydrazyl (DPPH) scavenging and metal chelating activity (Langley-Evans, 2000; 
Nanjo et al., 1996; Valentao et al., 2001). 
According to Yang et al. (2011) DS provide 25% of dietary total antioxidant capacity 
in US adults. In the last years, it has become easier to find in the market several new 
products claiming antioxidant properties. Moreover, these are becoming an important 
parameter to assess products’ quality and in the future antioxidant properties can be part of 
DS labelling (Almeida et al., 2011; Costa et al., 2012). Polyphenolic phytochemicals are the 
most frequently occurring phytochemicals in DS with in vitro antioxidant properties 
(Proteggente et al., 2002). As mentioned above, antioxidant activity of plant extracts or 
purified bioactive compounds has been intensely researched. However, data regarding 
antioxidant activity of formulations already marketed is scarce (Almeida et al., 2011; Costa 
et al., 2012). Data, in literature, regarding antioxidant properties in DS containing green tea 
is also spare. So, this study aims to evaluate antioxidant activity of six green tea DS 
marketed in Portugal, using different antioxidant assays.  
 
Methods 
 
Chemicals 
 
Nitroblue tetrazolium (NBT), 2,2-diphenyl-1-picrylhydrazyl (DPPH), reduced form 
of nicotinamide adenine dinucleotide (NADH), N-phenylmethazonium methosulfate (PMS), 
quercetin, and ferrozine were from Sigma-Aldrich (St. Louis, MO, USA). Ascorbic acid and 
pyruvate were purchased from Panreac (Barcelona, Spain). Ethylenediaminetetraacetic 
acid (EDTA) was purchased from VWR (Portugal). All other chemicals were of analytical 
reagent-grade.  
 
Samples and Samples Preparation 
 
Samples were DS containing green tea commercially available in Portugal and labeled 
with antioxidant activity. Six samples (three DS with only green tea as an active ingredient 
and three DS with multi-ingredients) were selected from pharmacies, parapharmacies and 
health food stores. In order to compare its antioxidant activity, samples were prepared using 
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the formulation available: pill and capsule. Samples A, C and D are mixtures, whereas 
samples B, E and F represent green tea only (Table I). 
 
Table I - Composition of study samples 
Sample Composition Formulation 
Label’s recommended 
daily dose 
A 
 Green Tea and Grape Seeds Lyophilized 
Coextract (gallic acid 20% procyanidins), 
300 mg; Dandelion (root), 60 mg;  
(caffeic acid derivatives 0.18%); Green tea 
leaf (powder), 548 mg 
Capsule Three capsules/day 
B 
Green tea (Camellia sinensis (L.) Kuntze) leaf  
(minimum of 2% caffeine), 300 mg 
Capsule 
Two capsules before 
breakfast + two 
capsules before lunch 
C 
Green tea (minimum of 6% caffeine), 300 
mg;  Guarana (minimum of 22% caffeine), 
300 mg; Bitter orange, 300 mg; L-carnitine, 
200 mg; Cocoa, 100 mg; Choline, 82.5 mg; 
Chromium, 40 µg 
Pill 
Two tablets/day (after 
meals) 
D 
Selenium, 200 µg; Chromium, 160 µg; Iodine, 
160 µg; Green tea extract, 520 mg; Acetyl-
L-tyrosine, 400 mg; Caffeine, 400 mg; 
Rhodiola rosea, 320 mg; Coleus forskohlii, 
320 mg; Tyrosine, 200 mg; β-Sitosterol, 60 
mg; Phenylalanine, 80 mg 
Capsule 
In the first week start 
with one capsule 
30min before 
breakfast and before 
lunch. In the second 
week take two 
capsules each time. 
E Green tea leaf, 500 mg Capsule 
Two capsules after 
breakfast + one 
capsule before lunch 
F 
Standardized Green Tea Extract (leaf) 
polyphenols 200 mg (50%), 400 mg; Green 
tea leaf (powder), 100 mg 
Capsule 
one to two 
capsules/day at meals 
 
Each formulation was weighted and recommended daily dose of each DS was dissolved 
in 150 mL of distilled water in order to obtain the concentration of the stock-solution. Pills 
and the inner part of the capsules were dissolved in distilled water. Several dilutions of each 
DS were prepared to perform the antioxidant activity assays. 
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Antioxidant Activity 
 
Antioxidant activity of all samples was evaluated by DPPH radical scavenging 
activity, superoxide radical scavenging activity, and Fe2+ chelating activity. The sample 
concentration providing 50% inhibition (IC50) was obtained by plotting the inhibition 
percentage against sample concentrations. EDTA, ascorbic acid and quercetin were used as 
standards. 
 
DPPH radical scavenging activity 
 
DPPH scavenging procedure was performed in accordance with Lima et al., (2007) with 
minor modifications. After addition of 19.4 µL of each sample to DPPH (175 µL), the 
reduction of DPPH absorption was measured at 515 nm using a plate reader 
spectrophotometer. Radical scavenging ability was calculated using the following formula:  
 
𝐷𝑃𝑃𝐻 inhibition (%) =
𝐴𝑐𝑜𝑛𝑡𝑟𝑜𝑙− 𝐴𝑠𝑎𝑚𝑝𝑙𝑒
𝐴𝑐𝑜𝑛𝑡𝑟𝑜𝑙 
× 100                   A = Absorbance 
 
Superoxide radical scavenging activity 
 
This procedure was performed using the PMS-NADH nonenzymatic assay as 
previously described by Valentao et al., (2001). The reaction mixture used was: 26.1 µL of 
each sample + 75 µL NADH (166 µM) + 150 µL NBT (43 µM). After incubation at 30ºC for 3 
min, 10 µL of PMS (70.5 µM) was added. The absorbance was determined over time at 560 
nm. Superoxide radical scavenging ability was calculated using the following formula:  
 
Superoxide Radical Scavenging ability (%) = 100 x [(AC-AS)/AC], 
AC = absorbance of the control 
AS = absorbance of the sample (DS or standard) 
 
Fe2+ chelating activity 
 
This procedure was performed in accordance with Russo et al., (2005) with some 
modifications. Briefly, 50 μL of each sample at different dilutions were added to 50 μL of a 
ferrous sulphate solution (FeSO4) (0.12 mM of) and 50 μL of ferrozine (0.6 mM). The mixture 
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was then shaken vigorously and left at room temperature for 10 min. After incubation, 
absorbance was measured spectrophotometrically at 562 nm. The results were expressed 
as percentage of inhibition of the ferrozine – Fe2+ complex formation (Russo et al., 2005).  
 
Statistical Analysis 
 
GraphPad Prism® 7.0 (GraphPad Software, Inc; San Diego, USA) was used for statistical 
analysis. Data were presented as mean ± SD of at least three independent experiments.  
 
 
Results 
 
 In this study, antioxidant activities of DS containing green tea were evaluated by 
applying three common methods, iron chelating assay and DPPH and superoxide radical 
scavenging activity. All the DS proved to have free radical scavenging activity but to 
different extent (Table II). Scavenging activities of the Fe2+ chelating, DPPH and superoxide 
radical for all DS studied were observed in concentration-dependent patterns (data not 
shown). 
 
Table II - Antioxidant activities of studied DS samples.  
 IC50 (µg/mL) 
Sample 
Antioxidant Assay 
DPPH free radical 
Scavenging 
Superoxide radical scavenging 
Activity 
Fe2+ chelating 
ability 
A 39.3 ± 16.7 63.6 ± 7.6 n.d. 
B 34.0 ± 17.4 62.8 ± 4.5 2681.6 ± 92.0 
C 45.5 ± 1.0 265.3 ± 5.4 n.d. 
D n.d. 57.7 ± 0.8 n.d. 
E 31.6 ± 2.3 65.6 ± 0.3 n.d. 
F n.d. 44.7 ± 3.2 n.d. 
n.d.:  not determined 
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In the measurement of DS scavenger activity against the DPPH radical, sample E 
showed the best IC50 value (IC50 = 31.6 ± 2.3 μg/mL) when compared to other samples. 
Antioxidant activity of tested samples, based on IC50 values, followed the order: sample E > 
sample B > sample A > sample C. In samples D and F, the determination was not possible, in 
the range of tested concentrations. According to the results, none DS is as good as the 
standard quercetin (IC50 = 5.2 ± 0.1 μg/mL (Table III). 
Analysing the results for superoxide radical scavenging activity, best IC50 value was 
shown by sample F (44.7 ± 3.2 μg/mL), followed by samples D, B, A, E and C. In all samples 
(except for sample C), IC50 values were lower than the positive control, ascorbic acid (IC50 = 
77.5 ± 10.9 μg/mL, a well-known antioxidant (Table III).  
Finally, in case of iron chelating activity, only sample F presented an IC50 value 
(2681.6 ± 92.0 μg/mL). Again, and according to the results, all DS are not as good as the 
standard EDTA (5.4 ± 0.2 μg/mL). (Table III). 
 
 
Table III - IC50 values for standards.  
Antioxidant Assay Positive control IC50 value (μg/mL) 
DPPH Quercetin 5.2 ± 0.1 
Superoxide Ascorbic acid 77.5 ± 10.9 
Fe2+ chelating activity EDTA 5.4 ± 0.2 
 
 
 
Discussion 
 
Plants are a rich source of natural bioactive compounds and many of them can act 
as antioxidants (Noreen, Semmar, Farman, & McCullagh, 2017). Polyphenols are the most 
interesting group of green tea leaf components, and therefore green tea can be considered 
an important dietary source of polyphenols, particularly flavonoids (Cabrera, Artacho, & 
Gimenez, 2006). The role of flavonoids and related compounds, as components 
responsible, in part, for the protective effects of a fruit- and vegetable-rich diet has become 
an increasingly important area of human nutrition research (Del Rio et al., 2013).  
Dietary sources and intake of polyphenols contribute for health promotion and 
reduce the risk of chronic diseases (Bolling, McKay, & Blumberg, 2010). In vitro, animal 
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studies, and clinical trials employing biomarkers of oxidative stress status, provide strong 
evidence that green tea polyphenols may play a role in the risk and pathogenesis of several 
chronic diseases, especially cardiovascular disease and cancer. In addition, several studies 
have showed antidiabetic, antibacterial, anti-inflammatory, and hypocholesterolemic 
properties of green tea (Feng et al., 2001; Fernandez, Pablos, Martin, & Gonzalez, 2002; Pan, 
Jankovic, & Le, 2003). 
DS with antioxidant properties are marketed as single or multi-ingredient products, 
from natural or synthetic origin, and are presented in a variety of forms including tablets, 
pills, capsules, powders, drinks or supplements bars (Almeida, Barreira, Oliveira, & Ferreira, 
2011). In this study six DS were analysed. Its selection was based in the different 
components included in the available formulations, either as single active components or in 
different combinations (Table I). The antioxidant components comprise hydrophilic (e.g. 
polyphenols) molecules and natural extracts (e.g. Rhodiola rosea, Paullinia cupana and 
Coleus forskohlii) (Arantes et al., 2018; Sista et al., 2018; Takshak & Agrawal, 2015).  
Tea polyphenols act as antioxidants in vitro by scavenging ROS and RNS and 
chelating redox-active transition metal ions (Lima et al., 2007). Therefore, in order to 
extensively characterize the antioxidant potential of DS with green tea extracts there is a 
need for combining several different methods. In this study, antioxidant activities of 
different DS samples were assessed, by applying different methods, based on metal ion 
chelation and free radical scavenging. As expected, results regarding antioxidant activity of 
the different commercial dietary antioxidant supplements show great variability, reflecting 
their diverse composition and concentrations (Table II).  
DPPH radical scavenging assay is a commonly method used due to excellent 
reproducibility, stability, commercial availability and by the fact that it is an easy 
measurement method (Silva et al., 2004).  DPPH is a stable nitrogen-centered free radical, 
the color of which changes from purple to yellow upon reduction by either the process of 
hydrogen- or electron- donation (Nabavi, Ebrahimzadeh, Nabavi, Eslami, & Dehpour, 2011). 
As a result of a color change from purple to yellow the absorbance decreased when the 
DPPH radical was scavenged by an antioxidant through donation of hydrogen to form a 
stable DPPH-H molecule (Matthaus, 2002). Several studies have shown green tea 
antioxidant activity by DPPH scavenging assay (Frei & Higdon, 2003; McKay & Blumberg, 
2002; Satoh, Tohyama, & Nishimura, 2005). Dietary supplements A, B, C and E were able to 
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reduce DPPH in a dose dependent manner with the IC50 values ranging from 31.6 to 45.5 
µg/mL. In this study sample E has the lowest IC50 (31.6 ± 2.3 μg/mL, followed by sample B 
(34.0 ± 17.4 μg/mL). These two samples represent DS with only green tea has a bioactive 
ingredient. A lower IC50 value represents a stronger DPPH scavenging capacity, and a higher 
antioxidant potential (Lima et al., 2007).  
The antiradical activity against superoxide radical can be measured using a 
nonenzymatic assay using a PMS-NADH system (Valentao et al., 2001). Superoxide radical 
is formed in almost all aerobic cells as a result of one oxygen electron donation, being 
relevant in the oxygen toxicity mechanism (Magalhaes et al., 2008). Superoxide is a week 
radical but it may cause severe damage to the cell by generating hydroxyl radical and singlet 
oxygen (Ahmad et al., 2013). In this assay, sample F presented best value of IC50 (44.7 ± 3.2 
μg/mL). This sample can deliver a high recommend daily dose of green tea to consumer 
(1500 mg) which may explain the observed results.  
Transition metal ions, such as Cu2+ and Fe2+, can catalyze the generation of reactive 
oxygen species and result in lipid peroxidation and DNA damage (Stohs & Bagchi, 1995). 
Therefore, the ability of tea polyphenols to chelate metal ions, such as iron and copper, may 
contribute to their antioxidant activity by preventing redox-active transition metals from 
catalyzing free radical formation (Rice-Evans et al., 1997). However, it is not clear whether 
metal chelation is a physiologically relevant antioxidant activity, because most transition 
metal ions are bound to proteins in vivo where they cannot participate in metal-catalyzed 
free radical formation (Frei & Higdon, 2003). In the Fe2+ chelating ability, ferrozine reacts 
with ferrous ions to form a magenta complex that absorbs at 562 nm (Lopez et al., 2016). 
The absorbance is directly related to iron in the fly (Lopez et al., 2016). Green tea catechins 
possess well-established metal-chelating properties. Structurally important features 
defining their chelating potential are the 3´,4´-dihydroxyl group in the B ring (Hider et al., 
2001), as well as the gallate group (Guo et al., 1996; Kumamoto et al., 2001). However, in this 
study only one sample showed an IC50 value (2681.6 ± 92.0 μg/mL). Results observed in 
this assay can be explained by differences in green tea mechanism, dilutions used, or 
sample extraction methods (Chen, 2013).  
In all the assays performed, best results were given by a DS with only green tea as a 
bioactive compound. These results showed that DS containing green tea as single 
ingredient may be more effective as antioxidant compared DS with multi-ingredients, which 
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are not in agreement with the study performed by Almeida et al., (2011). Almeida et al., (2011) 
showed that, considering DPPH scavenging activity, a DS containing vitamins A, C and E, L-
cysteine chloridrate, powdered extracts of green tea, red wine and pycnogenol, zinc 
glycinate, taurine, L-glutathione, manganese glycinate, Spirulina, G. biloba, S. marianum and 
Gotu kola extracts, selenomethionine, copper lysinate and riboflavin-5-phosphate; and a 
DS containing  disodium selenium, vitamins A, C and E were the most powerful supplements 
(with a IC50 value of 0.052 ± 0.001 µg/mL and 0.12 ± 0.02 µg/mL, respectively).  
Several studies have been evaluating this antioxidant potential of single green tea 
products or extracts. Lowe, Gana & Raham (2015) indicated that a green tea extract, taken 
as a DS, for 14 days can increase the leukocyte activity and the total plasma antioxidant 
status (Lowe, Gana & Raham, 2015). Another study performed by Yu et al., (2017), which 
was a randomized, double-blinded, placebo-controlled phase II clinical trial, demonstrated 
that high-dose of green tea extract intake, for approximately 12 months, were associated 
with liver enzyme elevation in a small proportion of healthy postmenopausal women (Yu et 
al., 2017).  
In contrast, several authors showed better antioxidant activity for green tea 
combined with other substances. For example, El-Begati (2016) found that a mixture of 
grape seed and green tea extract was more effective as antioxidant than each extract 
separately. Another study performed by Taghizadeh et al., (2017) indicated that taking 
green tea, capsaicin and ginger for 8 weeks among overweight women had beneficial 
effects on weight, BMI, markers of insulin metabolism and plasma GSH levels.  Finally, Liu 
Z., Lou, Jia, Wang & Li, (2016) concluded that there is a synergistic interaction with Potentilla 
Fruticosa L. leaves extract plus green tea extract regarding antioxidant activities. 
However, this synergic effect depends on the type of substances present in mixture 
and its concentration. For example, sample C has guarana (Paullinia cupana), bitter orange 
(Citrus aurantium) and cocoa (Theobroma cacao) extract, which were used principally for 
their content in caffeine and thermogenic effect. Citrus aurantium extract and its primary 
protoalkaloidal constituent p-synephrine are extensively used in weight management 
products and as thermogenic agents (Stohs, Preuss, & Shara, 2012). Sample D, besides 
green tea, has Rhodiola rosea and Coleus forskohlii extract. Rhodiola rosea has biologically 
active substances including flavonoids and phenolic glycosides (salidrosides and rosavin) 
(Kelly, 2001). In vitro studies have been shown its antioxidant potential (Battistelli et al., 
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2005; De Sanctis et al., 2004). However, in a randomized double-blind trial with R. rosea 
supplementation (600 mg/day), no effects were observed in exercise-induced muscle 
damage and inflammatory markers (Jowko et al., 2018). In addition, R. rosea 
supplementation showed no influence on oxidative stress parameters (Jowko et al., 2018). 
 
 
Conclusion  
 
 The antioxidant activity of fruits and vegetables has been thoroughly investigated 
but less is known about this activity in DS. DS are formulated from different plant species, 
have different compositions, and concentrations of active ingredients, so it´s expected that 
they will vary in its antioxidant ability. In case of green tea, this plant is a higher phenolic 
source, however, antioxidant activity can vary based on botanical origin, preparation 
process, concentrations and forms. DS studied showed different antioxidant results at 
different assays performed. Also, DS containing green tea with other substances didn´t 
show better results than DS with only green tea extract. These results show the need to 
standardize DS in terms of its antioxidant capacity to match required doses to the oxidative 
status of consumers.   
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The prevalence of DS use has increased dramatically over the last years, and DS 
have become a matter of consumer interest. For that reason, concerns about ingredient 
misidentification, safety, and quality assurance continue to be important for the industry 
and the public. 
Regulators, health professionals and manufacturers often disagree on how much 
quality testing is necessary for supplements. However, DS have precautions of use, adverse 
effects and contraindications. For this reason, DS shouldn’t be regulated the same way as 
foods. In 2007, FDA created new good manufacturing practices rules. These guidelines 
should be extended and/or adapted to Europe, Portugal included, where DS regulation 
seems to be incomplete and poor. In Portugal, many herbal products are produced in the 
country or imported, and sold in places where, in a general way, dietetic products are 
dispensed. So, these products are not subject to intervention from Autoridade Nacional do 
Medicamento e Produtos de Saúde, I.P. (INFARMED), and therefore their quality, safety and 
efficacy is not guaranteed for the consumer. According to Portuguese law, DS are not 
intended to diagnose, treat, cure, or prevent any disease, so disease claims are prohibited in 
these products. However, indications of use may be a request in products to promote their 
selling. Demonstrating efficacy requires clinical studies with well-defined products and 
rigorous experimental designs, and the studies must be replicable. 
Green tea is one of the world’s most popular beverages and has been associated 
with a number of health benefits. However, the plant also has drug interactions, adverse 
effects, contraindications and precautions of use. Given the widespread use of green tea 
supplements and data suggesting benefits with respect to disease prevention, the work 
herein presented intended to study the information on websites, labels and antioxidant 
activity of DS with green tea marketed in Portugal.  
Consumers are increasingly using the Internet as a source of health information or 
to buy health products, like DS. However, the content of health information on websites is 
unregulated, so consumers are exposed to information that may be inaccurate and 
misleading. This thesis showed that the use of validated instruments is necessary to reduce 
the risks from patients accessing misinformation. Also, Portuguese regulation does not 
obligate manufactures to describe scientific information at DS labels, just because DS are 
regulated as foods and consequently are considered safe products. However, this kind of 
information is essential for consumers safe and can interfere with conventional treatments. 
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This thesis also showed that the majority of websites analyzed provide insufficient or poor 
quality information about the benefits and risks of product use. It was also observed some 
differences in the quantity and type of information between different types of websites 
(pharmacies, parapharmacies, health food stores and websites without physical space). If 
consumers not have a follow-up by a health professional, they may not know the real 
dangerous of green tea DS intake. Based on the results found in this thesis, we recommend 
more rigorous regulation for the online marketing of DS. 
 Nowadays, it is possible to find in the market several products claiming their 
antioxidant activities, and this kind of information is becoming an important parameter to 
assess the quality of a DS. However, data regarding antioxidant activity of products already 
marketed is scarce, because labels often lack information regarding effective antioxidant 
capacity values. 
 In this thesis, DS analyzed showed different antioxidant results with different 
assays performed. Also, DS containing green tea with other substances didn´t show better 
results than DS with only green tea extract. In case of green tea, this plant is a higher 
phenolic source, however, antioxidant activity can vary based on botanical origin, 
preparation process, concentrations and forms. Clinical studies are not required, and 
pharmacological actions are not guarantee. Manufacturing practice rules should be 
necessary for standardize DS formulation and ensure its quality.  
Dietary supplements can offer significant health benefits, but may also cause an 
increased health care cost and adverse effects. Appropriate clinical trials that evaluate the 
use and efficacy of different DS may be critical for our health care system. Challenges in 
supplement science and its regulation provide new opportunities for researchers and 
regulators to work together both nationally and internationally, and this cooperation will 
have an impact on health care. Some steps can be made in order to have a better DS 
regulation. These included reclassification of the available products with a review of their 
advertised benefits and potential risks; manufacturers of DS should follow to the same 
standards as drug manufacturers; and regulatory agencies should encourage the 
implementation of an adequate post marketing surveillance program. 
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Limitations 
This study is limited to searching websites with DS in the form of tablets and 
capsules; to searching websites based on a specific plant extract (green tea); also to a 
relatively low number of websites and products. All of the search was performed within a 
three month time period, so changes may have occurred during this time, and affect data. 
We choose only Portuguese websites, and could be interesting to compare different 
realitys.  
 
Future Perspectives 
As future perspectives it could be interesting to analyze other information present 
on websites, namely the scientific references supporting the DS offered, testimonials from 
consumers; prices and extra information provided by websites. It could be also important to 
extend the selected websites to other categories (like supermarkets) or websites from 
other countries. Antioxidant studies and legal requirements analyzed should be amplified to 
other DS categories with high consumption by population (e.g. multivitamins, sports 
nutrition). In case of antioxidant activity, could be interesting to perform other assays [e.g. 
thiobarbituric acid assay (TBA); 2,2'-azinobis(3-ethylbenzothiazoline-6-sulfonic acid) 
(ABTS) assay; and ferric reducing/antioxidant power (FRAP) assay}. We could also 
determine the total phenolic and flavonoid contents of the DS in order to compare these 
results to antioxidant activity.   
 
 
